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Glucocorticoids (GC) are powerful metabolic hormones with anti-inflammatory 
actions. Despite major side effects they remain widely prescribed therapies. GC 
regulates gene expression through an intracellular receptor (GR), which is a ligand 
activated transcription factor. Macrophages are innate immune cells and major 
targets of GC. Traditionally repression of pro-inflammatory genes in the context of 
an inflammatory stimulus has been considered the primary mode of action of GC in 
macrophages.  
The work described in this thesis has demonstrated that GC act primarily as inducers 
of gene expression in primary macrophages from both mouse and man, but the set of 
induced genes is very different between the two species.  Chromatin 
immunoprecipitation and sequencing (ChIP-seq) in each species using anti-GR 
antibodies revealed candidate enhancers in the vicinity of inducible genes that were 
generally not shared between mouse and man.   The differences in binding were 
correlated with DNA sequence changes at the enhancer sites between the two 
species, that caused gain or loss of predicted GR receptor-binding motifs.   
The mechanism of action of GC was investigated by imaging several different target 
loci using fluorescence in situ hybridisation in macrophage nuclei.  Chromatin at 
specific GC responsive loci was found to decondense within minutes of exposure of 
macrophages to the ligand.  The apparent decondensation was effect was maintained 
for at least 24 hours and was not prevented by inhibitors of transcription.  
The general principles of the GC response were shared between species. However 
the divergence found underlines the caution that must be used when translating 
specific findings from mouse to man. Additionally, the data support a role for GR 
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Effects of glucocorticoids in macrophages 
Introduction 1 




1.1.1 Discovery, use and problems 
 
Glucocorticoids (GC) are powerful metabolic hormones with anti-inflammatory 
actions. First isolated and brought to clinical use over 60 years ago (Hench PS, 
Slocumb CH, Polley HF, 1950), they produce dramatic alleviation of inflammation 
in the majority of cases. Their therapeutic impact combined with the efficiency with 
which they can be produced ensures that they remain the most widely prescribed 
anti-inflammatory therapies (Fardet et al., 2011; van Staa et al., 2000).  
GC are synthesised in, and secreted from, the zona fasciculata of the adrenal 
gland from a cholesterol precursor (Figure 1.1). Plasma GC levels fluctuate in a 
diurnal rhythm and are integrated with the autonomic nervous system such that 
release from the adrenals also occurs in response to stress. GC form the efferent limb 
of the hypothalamic-pituitary-adrenal (HPA) axis, a classical hormone feedback loop 
(Figure 1.2) (Nicolaides et al., 2015). Pro-inflammatory cytokines stimulate the HPA 
(Silverman and Sternberg, 2012) and dysregulation of this axis is linked to increased 
morbidity and mortality in humans with severe illness (Annane et al., 2000, 2009; 
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Figure 1.1 Steroidogenesis 
An overview of steroidogenesis showing the steps in production of GC from 
cholesterol. Also shown are the pathways that produce the related mineralocorticoids, 
estrogens and androgens. White highlights indicate changed moieties after each 
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Figure 1.2 The hypothalamic-pituitary-adrenal axis 
Schematic diagram illustrating pathways resulting in secretion and feedback control 
of GC through the HPA axis. CRH = corticotrophin releasing hormone, ACTH = 
adrenocorticotrophic hormone, GC = glucocorticoids, predominantly cortisol in man. 
Pro-inflammatory cytokines include for example Tumour Necrosis Factor alpha 
(TNFα), Interleukin 6 (IL6). 
 
Physiological GC have wide ranging effects, which act to maintain 
homeostasis, for example in intermediary metabolism, fluid balance, bone 
metabolism, psychology, development and the cell cycle (Nicolaides et al., 
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produce a litany of side effects (Table 1.1) making their longevity in the clinic all the 
more remarkable. The corollary of their many functions is that they have clinical 
efficacy in many situations that are not primarily inflammatory, from analgesia and 
anti-emesis to anti-cancer chemotherapy. Despite extensive investigation of the 
actions of GC, it remains the case that an alternative with equivalent efficacy but 
reduced side effects has not yet been developed. It may be argued that this is in part 
because our knowledge of the mechanisms by which GC act remains incomplete. 
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Table 1.1 Side effects of glucocorticoid therapy 
Eye increased risk of cataracts 
 increased risk of glaucoma 
Central nervous system mood disorders 
 psychosis 
 memory impairment 
 increased risk of stroke 
Cardiovascular atherosclerosis 
 hypertension 
 heart failure 





Metabolic fat redistribution (truncal obesity) 
 insulin resistance 
 raised fasting glucose 
Renal fluid retention 
Genito-urinary menstrual irregularity 
Musculoskeletal osteoporosis 
 avascular necrosis 
 growth impairment in children 
 muscle weakness 
Skin thinning 
 purpura 
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1.1.2 Towards a mechanism for glucocorticoid action 
 
Highly lipid soluble (Figure 1.1,Figure 1.4) GC diffuse freely into cells. Intracellular 
levels of active GC are regulated by 11β-hydroxysteroid dehydrogenase enzymes and 
these can modulate inflammation (Chapman et al., 2006; Hadoke et al., 2013). Inside 
the cell GC act via an intracellular receptor (GR), which has the general structure 
common to receptors for other steroidal hormones such as androgens and 
progesterone (Oakley and Cidlowski, 2011) (Figure 1.3). GR is produced from a 
single gene in all species examined (Lu and Cidlowski, 2004) and has two main two 
isoforms GRα and GRβ produced by alternate splicing (Hollenberg et al., 1985; 
Oakley and Cidlowski, 2011), the major difference being that GRα binds ligand and 
induces expression of GC sensitive reporter genes whilst GRβ does neither (Lu and 
Cidlowski, 2004). It has become clear that GRβ is likely to have a role in regulating 
GC sensitivity (Gross and Cidlowski, 2008), but it does not respond directly to GC, 
rather it acts indirectly in balance with GRα. This thesis is focused on relatively 
acute responses to GC therefore the abbreviation GR is used to mean GRα unless 
stated otherwise. 
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Figure 1.3 Schematic diagram of the glucocorticoid receptor 
The main domains of the glucocorticoid receptor are shown in grey. Red bars 
indicate regions with identified roles. The position of the mutant A458T is given, 
(see text). NTD = N-terminal domain, DBD = DNA binding domain, H = hinge 
region, LBD = ligand binding domain. AF-1 and AF-2 = Activator Function 1 & 2 
involved in interactions with other factors. Dim = dimerization. Chaperone = domain 
interacts with GR chaperone proteins such as HSP90. Small figures represent the 
amino acid position. 
 
In the non-stimulated state GR is held in the cytoplasm bound to a chaperone 
complex, which is involved in receptor maturation and modulates ligand affinity. 
Components of the chaperone complex include heat shock proteins (40, 70 and 90), 
p23 and the immunophilins FKBP5 or FKBP4 (Oakley and Cidlowski, 2011; 
Vandevyver et al., 2012). Ligand binding results in conformational changes in GR 
and a switch from FKBP5 to FKBP4 binding. FKBP4 interacts actively with the 
cytoskeleton, via the ATP utilising motor protein dynein, increases the affinity of GR 
for GC and is necessary for efficient GR signalling (Wochnik et al., 2005). 
Conversely, high levels of FKBP5 reduce the binding affinity of GR for GC and have 
been associated with the glucocorticoid resistance observed in some new world 
primates (Denny et al., 2000). Binding of GC also exposes nuclear localisation 
signals and the receptor, assisted by the chaperone complex, translocates rapidly to 






1 421 486 528 777
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the nucleus (Vandevyver et al., 2012). FKBP4 and FKBP5 can modulate the 
interaction of GR with both ligand, other chaperones and active transport along the 
cytoskeleton and thus can regulate GC sensitivity at several levels (Jääskeläinen et 
al., 2011; Vandevyver et al., 2012). 
Many modifications of natural GC have produced molecules with differing 
pharmacology. For example, the widely-studied synthetic glucocorticoid,  
dexamethasone is modified at 3 positions and has higher binding affinity for GR and 
minimal affinity for mineralocorticoid receptor (Figure 1.4). 
 
 
Figure 1.4 Structures of cortisol and dexamethasone 
Comparison of the 2D structures of cortisol, the major GC in humans and the 
commonly used synthetic GC dexamethasone. Differences are highlighted in blue, 
these lead to higher affinity for GR but minimal affinity for mineralocorticoid 
receptor (MR). 
 
 Nuclear GR can bind directly to DNA, classically as a homo-dimer (Nixon et 
al., 2013) recognising a Glucocorticoid Responsive Element (GRE). The GRE was 
identified initially from study of the promoter region of the tyrosine amino 
transferase gene and forms an inverted repeat of 6 base pairs, separated by a 3 base 
pair spacer (AGAACAnnnTGTTCT) (Strahle et al., 1987). Studies of genome wide 
Effects of glucocorticoids in macrophages 
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GR binding have shown that the consensus GRE motif is not always strictly required 
and substantial degeneracy may be tolerated (John et al., 2011; Reddy et al., 2009).  
GR also acts indirectly by binding other transcription factors such as NFκB 
and AP-1 (Ratman et al., 2013; Uhlenhaut et al., 2013) as well as by recruiting 
coregulators, for example GRIP1 (Lonard and O’Malley, 2012; Rogatsky et al., 
2002). Direct GR-DNA binding has been reported to occur at distal regulatory 
elements (enhancers), closer to induced than to repressed genes (Reddy et al., 2009). 
Binding is dynamic, with visualized occupancy times in the order of seconds 
(McNally et al., 2000; Voss et al., 2011) with equally dynamic effects on 
downstream transcription (Stavreva et al., 2009). Ligand and DNA binding events 
allosterically modulate the action of GR (Meijsing et al., 2009; Watson et al., 2013). 
The favoured model of gene repression by GR is interaction with other factors as 
described above – termed ‘transrepression’. An alternative mode of gene repression 
by GR has also been described via negative GR response elements (nGRE). The 
nGRE has the form CTCC(n)0-2GGAGA, where (n)0-2 indicates flexibility in 
spacing (Hudson et al., 2013; Surjit et al., 2011) and is thus distinct from the 
consensus GR binding elements (GRE). Binding at nGRE is monomeric on opposite 
DNA strands(Hudson et al., 2013). Repression is mediated by recruitment of co-
repressors nuclear receptor compressor (NCoR) and silencing mediator of retinoic 
acid and thyroid hormone receptor (SMRT) and histone deacetylases (Surjit et al., 
2011). 
 Non genomic mechanisms such as non specific membrane interactions and 
cytosolic or membrane GR may have a role in the response to GC (Stahn and 
Buttgereit, 2008). This thesis is concerned with the genomic effects therefore the 
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1.1.3 The role of GR dimerization and the ‘dissociated’ 
glucocorticoid 
 
The ideal anti-inflammatory agent acting via GR would dissociate the anti-
inflammatory and metabolic effects and thereby eliminate the side effects listed in 
Table 1.1. In theory, some effects of GR could be retained in a receptor that did not 
bind directly to DNA, but bound instead to other transcription factors (Ratman et al., 
2013).  A GR mutant thought to be dimerization incompetent and hence unable to 
bind canonical GRE, A458T (human, equivalent to A465T mouse, A477T rat) 
(GRdim) (Figure 1.3) has been identified, in which gene induction was ablated, but 
restraint of a pro-inflammatory stimulus was retained (Reichardt et al., 2001).  This 
opened the possibility of achieving the desired dissociation of GC’s beneficial and 
deleterious effects by activating GR without inducing dimer formation. However, 
subsequent studies indicated that dimerization deficient mutants retain the ability to 
induce gene expression (Frijters et al., 2010) and demonstrated homo and hetero 
dimer formation between GRdim and GRwt (Frijters et al., 2010; Presman et al., 2014).  
Possible explanations for the residual stimulatory activity include monomer driven 
induction, atypical hetero- or head to head dimerization (Nixon et al., 2013; Schiller 
et al., 2014).  
The equivalent rat GR dimerization mutation, A477T, led to altered DNA 
binding kinetics and transcriptional output when expressed in human U2OS 
osteosarcoma cells (Watson et al., 2013). The A477T mutant GR bound with lower 
affinity than wild type, which was attributed to reduced co-operativity since 
monomer affinities were comparable between mutant and wild type. The response to 
GC in cells expressing the mutant receptor was altered, with some genes more 
responsive, some less and some unchanged (Schiller et al., 2014; Watson et al., 
2013). Genes that were less responsive to the mutant receptor were enriched for local 
GR binding in wild type whilst those that were more responsive to the mutant 
receptor were more likely to have local GR bound in the mutant condition (Schiller 
et al., 2014). A double mutant of GRdim and a substitution in the ligand binding 
Effects of glucocorticoids in macrophages 
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domain, I634A, did appear to significantly reduce dimerization, but both gene 
induction and repression were still possible (Presman et al., 2014). 
Based upon these published findings, it appears unlikely that a therapy that 
activates GR but prevents dimerization will be able to cleanly dissociate the anti-
inflammatory and metabolic effects of GC. Greater understanding of the modes by 
which GR acts in a native context may allow fine-tuning of ligands to produce the 
same outcome. 
 




Chromatin is the name given to the complex of DNA and protein that is 
present in eukaryotic nuclei.   It is formed from units, called nucleosomes, of 
approximately 146 base pairs of DNA sequence wrapped around an octamer of 
histone proteins, H2A, H2B, H3 and H4 (Luger et al., 1997). Lower abundance 
variants of core histones are present such as H2A.Z, which is enriched in 
nucleosomes flanking the transcription start site and at other sites involved in gene 
regulation (Talbert and Henikoff, 2010). Histone proteins undergo many post-
translational modifications, which are associated with gene regulation and chromatin 
structure. For example acetylation of histone N-terminal tails by histone acetyl 
transferases (HATs) is associated with transcriptional activation, via charge 
neutralisation and by providing docking sites for bromodomain containing 
transcriptional regulators factors (Lee et al., 2010). Similarly trimethylation of 
histone 3 at lysine 4 (H3K4me3) by histone methyl transferases (HMTs) of the 
COMPASS (complex of proteins associated with Set1) family, is associated with 
active gene promoters (Shilatifard, 2006). These marks are dynamic; acetylation can 
be removed by histone deacetylases (HDACs) and lysine histone methylation can be 
removed by demethylases. Combinations of modifications occur within a given locus 
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providing an additional layer of regulatory information on top of the underlying 
sequence (Lee et al., 2010; Smith and Shilatifard, 2010).  
Nucleosomes are linked by spans of DNA with the linker histone H1 
associated, which has a role in both nucleosome positioning and higher order 
chromatin structure. In turn this higher order structure has a regulatory effect on 
DNA-protein, hence transcription factor, interactions (Li and Reinberg, 2011). 
Although gene dense regions are enriched in open chromatin, there is not a simple 
relationship between density of folding and activity; many inactive genes are found 
in open regions and active genes from gene poor regions may be found in condensed 
chromatin (Gilbert et al., 2004).  
Remodelling of chromatin occurs via the action of ATP-dependent 
remodelling complexes.  In eukaryotes there are 4 classes; switching 
defective/sucrose non fermenting (SWI/SNF), imitation switch (ISWI), 
chromodomain helicase DNA binding (CHD) and inositol requiring 80 (INO80) 
(Clapier and Cairns, 2009). Remodellers use the energy of ATP hydrolysis to change 
the state of chromatin by moving, ejecting or restructuring the nucleosome and thus 
enable DNA replication, translation and repair (Clapier and Cairns, 2009).  
 
1.2.2 Long range control of gene regulation 
 
1.2.2.1 Distal elements regulate transcription and have characteristic 
features 
 
Transcriptional output for a given gene is the result of integration of all 
regulatory influences and begins from promoter regions that overlap the transcription 
start site (TSS) for each gene (Lenhard et al., 2012). The pre initiation complex (PIC) 
docks at promoters; this contains general transcription factors and DNA dependent 
RNA polymerase II (RNAPII) which then transcribes the sequence. Elements distant 
from this core promoter region play an essential role in providing the complexity and 
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specificity in gene regulation that is required to form complex organisms (Levine, 
2010). Control of transcription by a specific DNA sequence from a distal site was 
was first demonstrated using a part of an animal virus, SV40, to drive β-globin 
transcription (Banerji et al., 1981). The sequence of the distal site, the SV40 
enhancer, consisting of two 72bp repeats, enhanced expression when placed up or 
downstream of the gene in either orientation (Banerji et al., 1981). It was described 
as an enhancer due to its positive effect on transcription and was later shown to bind 
multiple transcription factors such as AP-1 (Lee et al., 1987). Combinatorial binding 
of transcription factors is now know to be a general property of enhancers (Glass and 
Ogawa, 2006; Levine, 2010; Métivier et al., 2003; Villar et al., 2014).  
Other features of enhancers have also now been described. These include 
sequence conservation (Frazer et al., 2003), binding of co-activators, conserved 
patterns of histone modifications, nuclease sensitivity, and bi-directional 
transcription.  
Co-activators bind to transcription factors, but do not bind DNA or regulate 
transcription directly. The co-activator p300 and its paralogue CREB-binding protein 
(CBP) were initially identified as a binding partner for cAMP-response element 
binding (CREB) (Chrivia et al., 1993) but are now known to interact widely with 
other transcription factors, including steroid receptors(Holmqvist and Mannervik, 
2013).  They have acetyl-transferase activity and can acetylate histones, but also 
have several other domains that facilitate interactions. A combination of p300 and 
histone 3 lysine 4 monomethylation (H3K4me1) marks enhancers (Heintzman et al., 
2007; Visel et al., 2009; Wang et al., 2005). Loss of  MLL3/ MLL4 subtypes of 
mammalian COMPASS leads to loss of H3K4me1 predominantly at enhancers(Hu et 
al., 2013). The location of enhancer marks is cell type specific, reflecting 
transcriptional diversity between tissues (Andersson et al., 2014; Heintzman et al., 
2009). Acetylation of histone 3 lysine 27 (H3K27ac) is reported to mark a proportion 
of active enhancers, and is a modification that can be made by p300 (Heintzman et 
al., 2009; Holmqvist and Mannervik, 2013), whilst acetylation of histone 4 lysine 16 
(H4K16ac) is also found at enhancers in embryonic stem cells (Taylor et al., 2013).  
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Transcription factors that can bind DNA at sites not permissive to other 
transcription factor binding are described as pioneer factors. Recruitment of 
chromatin remodellers by pioneer factor can then result in nucleosome repositioning 
such that the site can bind other factors. For a given cell type the position of these 
sites is determined by a small repertoire of lineage specific transcription factors, for 
example in innate immune cells macrophages the ETS factor PU.1 is dominant 
(below, section 1.3) (Ghisletti and Natoli, 2013; Ghisletti et al., 2010; Heinz et al., 
2010).  
Enrichment for transcription factor binding and depletion of nucleosomes at 
regulatory sites leads to sensitivity to digestion by nucleases (Felsenfeld et al., 1996). 
Enhancer associated histone modifications intersect with areas of increased 
chromatin accessibility (Thurman et al., 2012), have RNAPII bound(De Santa et al., 
2010) and display a signature of bi-directional transcription (Andersson et al., 2014). 
Genome wide maps of DNA elements likely to have regulatory function have now 
been produced across several cell types (Andersson et al., 2014; Bernstein et al., 
2012; Yue et al., 2014). These maps confirm earlier genetic evidence, for example in 
study of the Shh locus (Lettice et al., 2003), that enhancers can lie upstream or 
downstream of their target TSS and many tens or hundreds of kb distant. 
Mediator is a large (30 subunit, >1MDa) co-activator complex(Tsai et al., 
2014). It interacts with RNAPII and multiple transcription factors, including GR, and 
is involved in the expression of a large proportion of genes (Malik and Roeder, 
2010). Mediator binding can be detected at both promoters and enhancers (Kagey et 
al., 2010; Malik and Roeder, 2010). Clusters of enhancers, referred to as super 
enhancers by their descriptors, have been defined in some settings on the basis of the 
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1.2.2.2 Models of long range regulation 
 
There is debate about how distant regulatory sites, such as those bound by 
GR, cause changes in target gene transcription (Pennacchio et al., 2013). One model, 
currently the most prevalent, proposes that the distant element binds activating 
factors and co-activators, such as Mediator (Kagey et al., 2010; Malik and Roeder, 
2010). This then forms a loop to come close to its target promoter, delivering the 
regulatory input required (Figure 1.5A) (Bulger and Groudine, 1999; Krivega and 
Dean, 2012). 
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Figure 1.5 Models of long range control of gene expression 
Simplified diagrams of proposed models of enhancer activity. A Transcription 
factors and the transcription machinery (yellow oval) bind to an enhancer (green 
rectangle). A loop may then form to the target promoter (right), bringing the factors 
required for gene activation to the promoter. Alternatively the transcription 



















machinery may run along the genome to reach the promoter and then activate the 
gene (left). B Recruitment of chromatin modifiers to an enhancer (blue oval) may 
induce a change to the chromatin state from repressive (left) to permissive (right) for 
transcription of a target gene.  
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The presence of loops has been inferred from results from the chromosome 
conformation capture (3C) family of assays. These methods are all based on 
formaldehyde cross-linking of cells, digestion of chromatin and re-ligation of DNA 
followed by reversal of cross-links to leave ligation products that enrich for genomic 
regions that were cross linked (Figure 1.6). These products can be analysed in 
various ways, from PCR to next generation sequencing, but for all interactions are 
inferred from an increase in detectable cross-link formation over background after 
formaldehyde treatment (Dekker et al., 2002; Dixon et al., 2012; Dostie et al., 2006; 
Lieberman-Aiden et al., 2009; Rao et al., 2014). An estimate of background can be 
made by digestion of a bacterial artificial chromosome (BAC) covering the region of 
interest, which is assumed to adopt a conformation lacking higher order structure. 
Interactions that are separated by non-interacting regions are then described as loops 
of chromatin. The critical step in these assays was thought to be proximity ligation 
under conditions of dilute DNA, where intra- rather than inter- molecular ligation 
should be favoured. However, the majority of 3C products actually come from the 
insoluble portion of cross-linked material that is present within intact nuclei 
(Gavrilov et al., 2013). Formaldehyde treatment fixes the global nuclear architecture, 
as measured using fluorescence microscopy, sufficiently to resist the harsh detergent 
treatments in 3C protocols, although there is a more homogenous structure when 
examined by electron microscopy (Gavrilov et al., 2013). A 3C contact reflects a 
combination of the tendency of two regions to cross link, their spatial proximity at 
the point of re-ligation and the mobility of the digested DNA ends. Hence for highly 
formaldehyde cross-linkable loci, such as those containing multiple lysine, 
tryptophan and cysteine residues in the associated proteins, a contact may be 
identified where the physical distance is high (Williamson et al., 2014). 
Formation of a loop requires either an active or energetically favourable 
process, along with a mechanism for specificity. At the beta globin locus it has been 
shown that a loop forms from the locus control region (LCR) and is required for 
normal transcription. In this case it is mediated by a specific transcription factor, 
LDB1, forming a homo-dimer (Deng et al., 2012; Krivega et al., 2014). Dynamic 
higher order structures nucleated on Mediator have been proposed, via its ability to 
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interact with activating factors as well as other factors with roles in chromatin 
organisation like the cohesin complex (Kagey et al., 2010; Malik and Roeder, 2010; 























Figure 1.6 Principles of chromosome conformation capture 
In chromosome conformation capture formaldehyde is used to cross link DNA and 
protein. This cross-linked material is then digested using a restriction enzyme. 
Ligation of this material prior to reversing cross-links favours formation of intra-
molecular ligation products. When cross-links are reversed interactions between 
pieces of DNA are inferred from the frequency of their ligation products, indicated 
above as ‘Captured interaction’. Red and green lines represent strands of DNA that 
are close together in the condition under study, Black lines = restriction sites that are 
cut by a specific restriction enzyme, Yellow = site of DNA-protein-DNA 
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Transcription factors and the transcription machinery bind to enhancers(De 
Santa et al., 2010). Scanning of RNAPII along the genome from enhancers to 
promoters is an alternative to loop formation (Figure 1.5A). Evidence of increased 
RNAPII in the region between the enhancer and promoter has been observed in a 
study of an androgen receptor responsive enhancer (Wang et al., 2005). There was no 
enrichment for the activating factors recruited to the enhancer and promoter in the 
intervening region. Hence, the observation was consistent with RNAPII scanning 
from enhancer to promoter rather than formation of a large chromatin conglomerate 
including all measured sites. How RNAPII could scan over long distances past other, 
non-regulated, genes is not clear. 
The RNA polymerase machinery is inherently unidirectional (Duttke et al., 
2015) however bidirectional transcription may often be observed (Seila et al., 2008), 
even at promoters. The antisense transcripts initiate from distinct sites on the reverse 
strand with similar sequence content to the main promoter (Duttke et al., 2015). Anti-
sense transcripts are short due to an enrichment for poly-A sequence and are rapidly 
degraded (Ntini et al., 2013). As described above RNAPII binds to enhancers (De 
Santa et al., 2010) and there is bi-directional transcription (Andersson et al., 2014). 
Short RNA molecules, enhancer RNAs (eRNAs), that appear to be functional can be 
produced by enhancer transcription (Gosselin and Glass, 2014; Li et al., 2013). In 
macrophages targeted degradation of eRNAs from the enhancers of Mmp9 and 
Cx3cr1, which are normally repressed by Rev-Erbs nuclear receptors, caused specific 
repression of the target genes (Lam et al., 2013). Expression of eRNAs adjacent to 
responsive genes in oestrogen sensitive cells increases after treatment with 
oestradiol. Interfering with eRNA expression reduces the response of the associated 
gene (Li et al., 2013). In the same study reduced cross-linked interactions were noted 
between enhancers and promoters when the eRNA was knocked down for 2 loci, 
NRIP1 and GREB1. Mediator can interact with eRNAs that are responsive to the 
androgen receptor (AR) (Hsieh et al., 2014) so this may be one mechanism by which 
these structural effects occur. Transcription can precede and facilitate the deposition 
of the histone marks that are used to define enhancers (Kaikkonen et al., 2013). 
Conversely, enhancers can provide a locus from which domains of transcriptionally 
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permissive chromatin expand (Figure 1.5B) (Bulger and Groudine, 2011; Fromm et 
al., 2011). 
 
1.2.2.3 Visualizing chromatin changes during gene regulation 
 
The proximity relationship between genomic loci at the 100kb-1.5Mb scale can 
be assessed by DNA Fluorescence In Situ Hybridisation (DNA FISH) (Yokota et al., 
1995). By this method it is possible to visualise specific sites in the genome by 
fluorescence microscopy, which can then be used to assess chromatin compaction 
(Chambeyron and Bickmore, 2004; Eskeland et al., 2010; Williamson et al., 2012; 
Yokota et al., 1997). Fosmid pairs flanking the locus of interest are selected and 
labelled. These can then be hybridized to paraformaldehyde fixed cells and their 
positions visualized by microscopy. The physical distance between two fosmid 
probes is then measured (Figure 1.7). Less compact chromatin is inferred from larger 
distances for the same genomic length in base pairs. For adherent cells this procedure 
can be done in 3 dimensions (3D) through capture and reconstruction of image stacks 
from cells grown on slides.  
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Figure 1.7 Schematic overview of DNA FISH 
In DNA FISH a probe (Fosmid) with sequence specificity to the genomic site of 
interest is labelled using random cutting and infill with labelled dUTPs (purple filled 
circles). These may be directly linked to fluorochromes or to easily detectable 
haptens e.g. Biotin-dUTP (Label). After fixing the cells of interest on slides the 
labelled probe and nuclear DNA are denatured (Denature) then hybridised at 37° 
(Hybridise). The probes are visualised directly (for directly labelled probes), or 
detected, e.g. for biotin with avidin conjugated to a fluorophore, then visualized 
using fluorescence microscopy (Detect). Combining different labels allows two sites 
to be marked and detected simultaneously with fluorophores that have different 
emission spectra. 
Image adapted from that at 
(http://commons.wikimedia.org/wiki/File:FISH_(Fluorescent_In_Situ_Hybridization.jpg) under the 
under the Creative Commons Attribution-Share Alike 3.0 Unported license. 
Denature
Label
Fosmid Fix cells on slides
Hybridise
Detect using fluorescent antibodies
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It appears that in 3D FISH key aspects of chromatin conformation are 
preserved (Markaki et al., 2012), but findings between 3C based and FISH based 
assays are not always consistent (Dostie and Bickmore, 2012; Williamson et al., 
2014). For example, the Hox genes are important in patterning during mammalian 
development and have been studied by both FISH and 3C based techniques. When 
inactive, Hox loci adopt a compact state by FISH (Chambeyron and Bickmore, 2004; 
Eskeland et al., 2010; Morey et al., 2007) and have multiple local interactions by 3C 
based methods (Montavon et al., 2011; Williamson et al., 2014). Activation of Hox 
genes is linked to decompaction and looping out of chromosome territories 
(Chambeyron and Bickmore, 2004; Chambeyron et al., 2005; Morey et al., 2007; 
Williamson et al., 2012). Direct comparison of activation of the Hoxd cluster 
demonstrated compatible findings between the two techniques: decompaction by 
FISH and loss of interactions by 5C (Williamson et al., 2014). Absence of part of one 
repressive complex (Polycomb repressive Complex 2, PRC2) showed unfolding by 
FISH across Hoxd and was mirrored by loss of 5C interactions. By contrast loss of 
another repressive complex (Polycomb Repressive complex 1, PRC1) showed 
unfolding by FISH but the 5C contacts were maintained. This may be due to the 
chromatin environment and the ability of the looped out regions to form cross links 
on formaldehyde treatment: the mutant models have different amounts of the amino 
acid residues that are most readily cross linked by formaldehyde (lysine, tryptophan 
and cysteine) at the Hoxd locus (Williamson et al., 2014). As discussed above, all 
ligation products from 3C based assays come from insoluble cross-linked aggregates 
from intact nuclei that have been treated with strong detergent, therefore it is difficult 
to infer chromatin structure from this data (Gavrilov et al., 2013).  
Interestingly, in contrast to the findings and interpretation of Williamson et al. 
(above), a high frequency of detected local interactions at active Hox loci captured 
by 5C in fibroblasts (Wang et al., 2011) and by 4C in mouse embryos (Noordermeer 
et al., 2011, 2014) was interpreted in a different way: they suggest that the active 
locus is more compact.  
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1.2.2.4 Topology associated domains 
 
 High throughput ‘C’ techniques have led to the identification of higher order 
structures termed topology associated domains (TADs) (Dixon et al., 2012). These 
are self-interacting genomic regions of approximately 900kb in size and are reported 
to be largely invariant between cell types and even species, hence they are perhaps 
less likely to change in response to stimulus. Recent work suggests that dynamic 
changes within TADs can be quantitatively linked to regulation of transcription, at 
least at loci involved in X inactivation (Giorgetti et al., 2014).  
Another feature of genome organisation is DNA supercoiling. DNA 
supercoiling occurs when twist is induced in the helix by the passage of RNAPII 
(Villeponteau et al., 1984) resulting in domains of under and over wound DNA 
(Naughton et al., 2013). Domains of under wound DNA correlate to more open 
chromatin and active genes (Naughton et al., 2013) and are also remodelled by the 
activity of RNAPII and topoisomerase I. 
 
1.2.3 GC effects on chromatin 
 
Active chromatin remodelling complexes are involved in gene regulation by GR 
(Engel and Yamamoto, 2011; John et al., 2011; Trotter and Archer, 2007). Much of 
this work has derived from pioneering studies using murine cell lines that have the 
GC responsive Mouse Mammary Tumour Virus (MMTV) integrated in a tandem 
arrays containing 800-1200 GRE (Richard-Foy and Hager, 1987; Zaret and 
Yamamoto, 1984). The ATPase subunit of the SWI/SNF remodelling complex, Brg1, 
has been studied in the context of the GC response. Loading of Brg1 to the MMTV 
array in vitro rapidly follows GR binding (Nagaich et al., 2004) and Brg1 been 
shown to interact dynamically with MMTV in live cells (Johnson et al., 2008). 
Further, in the presence of a dominant negative form of Brg1 a subset of genes had 
reduced, although not ablated, response (John et al., 2011). 
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GR binding is largely constrained by, but also able to remodel the pattern of 
open chromatin measured by nuclease sensitivity (Biddie et al., 2011; Burd and 
Archer, 2013; John et al., 2008, 2011), if only at a minority of GR bound sites. Large 
scale re-organisation of chromatin was not observed in response to GC (Hakim et al., 
2011). Rather, GC acts locally on the background of pre-existing nuclear architecture 
by increasing the frequency of pre-existing regulatory contacts (Hakim et al., 2011). 
At present no studies visualising the dynamics of higher order chromatin responding 




1.3.1 Overview and relevance 
 
Macrophages are cells of the innate immune system involved in inflammation and 
tissue repair, as well as normal cell growth and development (Hume, 2008; Wynn et 
al., 2013). They differentiate from precursors under the influence of colony 
stimulating factors CSF1 and GMCSF.   The traditional view is that macrophages 
derive from circulating monocytes and this is certainly the case in large measure 
within inflammatory lesions.  However, in mice at least, there is also a role for local 
self-renewal of tissue macrophages seeded early in development and for proliferation 
of populations of tissue macrophages in response to inflammatory stimuli (Jenkins 
and Hume, 2014; Wynn et al., 2013).  Macrophages are a substantive cell population 
in all tissue, and are particularly focused in areas potentially exposed to injurious 
stimuli and pathogens. Reflecting the pervasive nature of inflammatory processes, a 
role for macrophages has been posited in virtually all medical conditions (Gosselin 
and Glass, 2014; Wynn et al., 2013). 
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1.3.2 Macrophage response to GC 
 
A feature of macrophages is their ability to detect and respond dynamically to 
stimuli. The most intensively studied response is that following exposure to bacterial 
lipopolysaccharide (LPS), a Toll-like receptor 4 agonist which generates a rapid and 
dramatic transcriptional response, producing a cascade of regulated genes both 
induced and repressed (Hume, 2012; Hume and Freeman, 2014). An initial cohort of 
induced genes, including for example TNF-alpha, are regulated at the level of 
elongation by pausing RNAPII (Hargreaves et al., 2009). Later genes are regulated 
by transcriptional regulation directly downstream of the TLR4 signalling cascade, 
through autocrine responses to cytokines produced by the initial response and in a 
cascade of induction or repression by induced transcription factors (Hume, 2012). 
  There is a growing realization that gene regulation from enhancers is critical 
to both specify cell type and define responses to stimuli (Andersson et al., 2014; 
Bernstein et al., 2012; Gosselin et al., 2014; Lavin et al., 2014; Yue et al., 2014). The 
enhancers involved in the LPS response have been mapped in mouse macrophages 
using a combination of H3K4me1 and binding p300 (section 1.2.2) (Ghisletti et al., 
2010). These sites are important for directing the binding of other transcription 
factors(Heinz et al., 2010) and are highly enriched for binding of the lineage defining 
ETS transcription factor PU.1 (Barozzi et al., 2014; Natoli, 2010). A subset of 
inducible enhancers, sites that gain H3K4me1 after a stimulus, has also been shown 
for several stimuli including LPS (Ostuni et al., 2013).  
Macrophages are major targets of GC. They express GR at high levels; in the 
mouse at relatively higher levels than in several other immune cell types (Lattin et 
al., 2008; Wu et al., 2009). Much of the research on therapeutic GC actions has 
focused on gene repression in the context of pro-inflammatory stimuli such as LPS 
(Chinenov et al., 2014; Ogawa et al., 2005; Uhlenhaut et al., 2013). However, 
immune cells such as macrophages also respond directly to GC in the absence of any 
other stimulus with changes in cell survival, proliferation, morphology and 
phagocytosis (Ehrchen et al., 2007; Galon et al., 2002; van de Garde et al., 2014; 
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Varga et al., 2008). GC oppose the actions of the major macrophage growth factor, 
CSF1 (Hume and Gordon, 1984) and can cause monocytopenia (Steer et al., 1997). 
Hence, there are good reasons to understand the direct actions of GC alone as a 
regulator of macrophage function.   
Data for a single time point have been published for mouse bone marrow 
derived macrophages (mBMDM) responding to a high dose of dexamethasone (1uM, 
16h) – a specific ligand for GR (Uhlenhaut et al., 2013). This model serum starved 
and removed CSF1 before treatment and showed a limited number of genes 
responding (32 reaching log2 fold change >1.5). Binding data for GR from chromatin 
immunoprecipitation followed by sequencing was also presented in this study, 
although the stated aim was to capture indirect interactions rather than direct GR-
DNA binding. Dual cross-linking with both formaldehyde and glutaraldehyde 
disuccimide found ~10,000 putative GR interaction sites (Uhlenhaut et al., 2013). 
The interactions detected included many that contained known partner motifs, but 
relatively few that contain a GRE (5% at the peak centre) and hence would be likely 
to directly bind GR. The large number of sites and small number of genes also makes 
regulatory relationships difficult to discern. More recently an early responding gene 
set has been reported in mBMDM where they retained serum and CSF1 (100nM, 1h) 
(Chinenov et al., 2014). Similar to the LPS response (Hume, 2012; Raza et al., 2014), 
a predominance of transcription factors was observed in the early responding genes 
(Chinenov et al., 2014). Single time point data from human monocyte derived 
macrophages (hMDM) differentiated with GMCSF has been reported as part of a 
wider screen of the response to multiple stimuli, but no GR binding data is available 
(Xue et al., 2014). The characterisation of the response to GC in macrophages 
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1.4 Models, conservation and divergence 
 
Model systems necessarily underlie much scientific research. The primary model 
system for mammalian biology is the mouse and a great deal of understanding has 
been gained from its use. This success reflects the experimental tractability of the 
species along with moderate physiological and DNA sequence conservation with 
humans. However it is also clear that there are significant differences between mice 
and men when one examines specific details, quite apart from the obviously 
divergent physiological challenges.  
A comparison of mouse models of inflammatory illness with the corresponding 
human conditions found very limited overlap in the transcriptional response (Seok et 
al., 2013). The are some similarities and parallels if strictly orthologous genes are 
considered, but these are in the minority (Takao and Miyakawa, 2014). The 
differences between mice and men are less surprising when one considers the 
divergence between macrophages of inbred mouse strains responding to 
inflammatory stimuli (Raza et al., 2014; Wells et al., 2003) attributable to turnover of 
binding sites for lineage specific and stimulus specific transcription factors between 
strains (Heinz et al., 2013). The differences may also contribute to costly failures in 
translating therapy for sepsis, severe systemic inflammation, from animal models to 
man (Annane et al., 2013; Kerschen et al., 2007). 
As discussed above (sections 1.2.2, 1.3.2) regulatory sites that lie distant in the 
genome from their target promoters are now recognized as crucial in controlling gene 
transcription (Andersson et al., 2014; Stergachis et al., 2014; Vierstra et al., 2014; 
Yue et al., 2014). Variability of factor binding at these sites can be a source of 
phenotype diversity between species (Villar et al., 2014). This variation can accrue 
rapidly within species and has been fixed in the different inbred mouse strains 
(Stefflova et al., 2013). The pattern of use of these sites is defined by the 
environment in macrophages (Gosselin et al., 2014), with differentiated resident 
macrophages’ enhancer landscapes being reprogrammed when transplanted (Lavin et 
al., 2014). 
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The cis-regulatory landscapes are quite different between mouse and man 
(Stergachis et al., 2014; Vierstra et al., 2014; Yue et al., 2014) and this difference is 
particularly concentrated in sites associated with the immune response (Vierstra et 
al., 2014; Yue et al., 2014). Consistent with this, comparative analysis of 
macrophage gene expression after an inflammatory stimulus has shown that, as 
described above between inbred mouse strains, innate immune responses are very 
different between mouse and man (Schroder et al., 2012). This inter-species 
divergence is likely driven by the evolutionary pressure of host pathogen interactions 
and is due in part to promoter sequence variation (Fairbairn et al., 2011; Schroder et 
al., 2012). 
 Given the roles of GC and macrophages in immunity, as well as the role 
emerging for enhancers in the response to GC, it is plausible that this response may 
also be divergent and that either local (Schroder et al., 2012) or distal (Heinz et al., 
















The physiology and pharmacology of GC are important in human and animal health. 
A large body of research has begun to map the pathways by which they have their 
many effects. Predominantly GC act via a nuclear receptor to regulate gene 
expression in a complex way, which may, as our understanding develops further, 
provide therapeutic opportunities. Gene regulation occurs within a complex dynamic 
chromatin environment, which is itself responsive to GC, and involves control by 
distant elements.  
Intimately involved in normal development, health and disease, macrophages 
are major targets for GC, but investigation of the response is less comprehensive than 
that for other stimuli such as LPS. Chromatin organisation at GC responsive loci in 
macrophages has not yet been examined. Study of dynamic responses to other stimuli 
in macrophages has shown evolutionary divergence between species and strains. If 
replicated in the response to GC this may be of clinical relevance. 
 
1.6 Thesis aims 
 
• To describe the response to GC in the most commonly used models of 
macrophage biology, hMDM and mBMDM using global gene expression 
profiling and receptor binding assays. 
• To assess similarity and differences between the two systems and explore the 
possible origins of any differences  
• To determine if there is local chromatin remodelling in response to GC in the 
context of primary macrophages at candidate loci and explore the mechanism. 
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Chapter 2: Methods 
 
2.1 Laboratory procedures 
 
2.1.1 Ethics 
Procedures involving human volunteers were approved by the South East Scotland 
NHS Research Ethics Committee. All volunteers gave informed consent. Animals 
were cared for and managed within the Roslin Institute’s guidelines for animal safety 
and welfare. 
2.1.2 Cell culture  
8-10 week male wild type C57BL/6 mice were culled by cervical dislocation. Bone 
marrow wash flushed from hind limbs and then cultured in RPMI supplemented with 
Penicillin/Streptomycin, Glutamax (Invitrogen), and 10% Foetal Calf Serum for 7 
days in the presence of rhCSF-1 at 104U/ml. Cells were then replated at 1x106 cells 
per ml and treated as indicated.  
 Human peripheral blood monocytes were isolated from blood samples by Ficoll 
gradient separation of buffy coats followed by MACS CD14+ve selection (Milteny). 
The full protocols are available on www.macrophages.com. They were then cultured 
as above for 7 days before being treated as indicated with dexamethasone (Sigma) 
100nM or ethanol vehicle. 
For DNA FISH mBMDM were differentiated as above then replated onto ethanol 
sterilised Superfrost (ThermoFisher) slides. Cells were left overnight to adhere 
before treatment as described. Where indicated transcriptional block was induced by 
4 hours pre-treatment of differentiated mBMDM with 2.5mg/ml α-amanitin (Sigma). 
Slides were washed  briefly in Phosphate Buffered Saline (160mM NaCl, 3mM KCl, 
8mM Na2HPO4, 1mM KH2PO4, from tablets prepared by MRC HGU technical 
services (Thermo), PBS) and fixed for 10 minutes in 4% paraformaldehyde.  Slides 
were then washed 3 times 3 minutes in PBS. Cells were permeabilised by washing in 
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PBS/0.5% TritonX for 5 minutes. After 2 further washes in PBS slides were air dried 
and stored at -80°C. 
2.1.3 RNA extraction and processing 
RNA was prepared using RNeasy column based extraction with on column DNase 
treatment (Qiagen). RNA quality was checked using a 2100 Bioanalyzer (Agilent). 
For RT-qPCR cDNA was prepared using SuperscriptIII (Invitrogen). Relative 
expression was determined using SYBR green on a LightCycler480 (Roche) 
compared with GAPDH as a reference. Primer sequences are given in (Table 2.1). 
For microarrays RNA was prepared using standard Affymetrix protocols and applied 
to the HT-MG430PM (mouse), or HT-U33plusPM (human) chip by Edinburgh 
Genomics.  
For expression analysis BMDM were prepared from 3 mice, treated, extracted and 
applied to the arrays separately (3 x 6 arrays). Four individuals provided donations 
for the hMDM , which were prepared, treated and applied to the arrays separately 
(4x6 arrays). 
2.1.4 Chromatin Immunoprecipitation  
 
Antibodies used for chromatin immunoprecipitation of mouse GR were BuGR2 
(raised against partially purified rat GR) 1µg/106 cells (ThermoFisher / Pierce), and 
normal rabbit IgG sc-2025 (Santa Cruz). For human GR ChIP we used Sigma 
Imprint™ anti-GR (raised against amino acids 304-428 of human GR), 1µg/106 cells 
and mouse IgG (Santa Cruz). 
20ul of Protein A Dynabeads (Invitrogen) per immunoprecipitation (IP) were washed 
once then diluted to 200ul in block solution (1xPBS, 0.5% BSA, +2ul 0.1M PMSF). 
Antibody was added and rotated for 3h at 4°C.  
Cells were washed gently once with PBS then cross-linked in tissue culture plates 
with 1% formaldehyde/RPMI at room temperature for 10 min (mouse) or 7.5min 
(human) and then quenched with 0.125M glycine. Cells were detached by scraping in 
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PBS then spun down at 400g for 5 minutes, resuspended and counted. For mBMDM 
10 million cells per IP were then taken on and lysed for 15 minutes on ice in 1%SDS, 
10mM EDTA, 50mMTris-HCL pH8.1 supplemented with Protease Inhibitors 
(Calbiochem), 1mM DTT and 0.2mM PMSF (Sigma). The solution was diluted in IP 
dilution buffer (0.1% Triton-X100, 2mM EDTA, 150mM NaCl, 20mM Tris-Hcl 
pH8.1) and sonicated using a Soniprep 150 to produce average fragment size 300-
500bp. Chromatin was spun for 10min at 10,000g 4°C then supplemented with 20% 
Triton-X100 to 1% and Bovine Serum Albumin (BSA) (Sigma) to 50µg/ml. Input 
aliquots were removed and stored at -20°. Chromatin was then added to the antibody-
bound Protein A Dynabeads (Life technologies) and rotated overnight at 4°C. Beads 
were washed 3 times for 10 minutes each in 1 - 1% IP dilution buffer, 2 - 1%Triton-
X100/0.1%Na-deoxycholate/0.1%SDS, 50mM Hepes pH7.9, 500mM NaCl, 1mM 
EDTA and 3 - 0.5%Na-deoxycholate/0.5%NP-40, 20mM Tris-HCl pH 8, 1mM 
EDTA, 250mMLiCl. Chromatin was extracted at 37°c for 15min on a vibrating 
platform in 100ul extraction buffer (0.1M NaHCO3, 1%SDS). To reverse crosslinks, 
samples were supplemented to 300mM NaCl, treated with RNaseA (Roche) then 
incubated for ~8h at 65°C. Proteinase K (Genaxxon) was added and samples 
incubated at 55°C for 1h. DNA was purified using the MiniElute PCR purification 
kit (Qiagen). Real-time qPCR analysis to determined percent input bound at known 
GR target loci was carried out on a LightCycler 480 System using SYBR Green 
Master Mix (Roche). Primers used are presented in (Table 2.1). For sequencing ChIP 
DNA was prepared and amplified using Illumina adapters and Tru-Seq multiplex 
primers then sequenced using a HiSeq-2500 by Edinburgh Genomics.  
 For hMDM the same protocol was followed with the following differences. 
Material was prepared from 4 volunteers, treated, fixed for 7.5 minutes and lysed as 
above. It was sonicated to a fragment size of 400-600bp and the chromatin pooled, 
25 million cells in total. This was split into 3 for the IP step and recombined at 
extraction. DNA was then isolated as above, split into 3 aliquots and blunt ended 
with Klenow (Roche), PNK (NEB) and T4 DNA polymerase (Roche). An 
overhanging A base was added using Klenow (-exo) (NEB) and Illumina adapters 
ligated overnight at 16o C with T4 DNA ligase (NEB). The IP samples were 
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recombined after ligation and then split again into 7 aliquots. Libraries were 
amplified from each of these aliquots using Illumina Tru-seq multiplex primers and 
Phusion high-fidelity DNA polymerase (NEB) and the resulting material pooled and 
sequenced by Edinburgh Genomics on a HiSeq-2500.  
Table 2.1 Primer sequences used for expression and ChIP RT-qPCR 




Fkbp5 GGACCACGCTATGGTTTTGG CTCTTTCACGATGGCAGCCT 
Klf4 CGTTGACTTTGGGGCTCAGG ACGCGAACGTGGAGAAGGAC 
Wee1 CCTCGGATCCCACAAGTGCT TGCTTCACCAGCTCCATTGC 
Ypel5 GGCGCCACTGGTAGAGCATT CCAGTGAGCATGACCCGATCT 
Irf2 GCCGGTGGAACGGATGCGAA CCGCATGCATCCAGGGGATCT 
Dio2 GGGCTGCGCTGTGTCTGGAA GGCCCCATCAGCGGTCTTCT 
Ccl2 CGGCTGGAGCATCCACGTGTT GAGTAGCAGCAGGTGAGTGGGG 
Cdc42ep3 CCTCCGGGCAGAAGCTAGGA GGGTCTTTCCGGAGAGCCAGTTA 
Tlr7 TCCTCCACCAGACCTCTTGATTCCA TCTTCCGTGTCCACATCGAAAACAC 
Cdkn1c ACTGCTGCGGCCAATGCGAA CAGACGTTTGCGCGGGGTCT 
Ednrb AGTGCATGCGCAATGGTCCC GGCCAGTCCTCTGCGAGCAA 
F13a1 AGAGCACCCTCTCAGGAGCACA TTATTGGGCGGGACTGCTCGC 
      
human     
PDK4 TGCCTGTGAGACTCGCCAACA TCCACCAAATCCATCAGGCTCTGT 
CEBPD GACAGCCTCGCTTGGACGCA TCGTAGAAGGGCGCAGGCTC 
MDM2 GGCGTGCCAAGCTTCTCTGTG ACCTGAGTCCGATGATTCCTGCTG 
BCL11A CGCGCGACGGTGTGAAGTTA TGGAGCTCCCAACGGGCCAT 
MXD1 GGATCCGGATGGACAGCATC GTCCGTGCTCTCCACGTCAA 
EHD1 CGTTTGGCAACGCTTTCCTC GGGGGTGTCGATGATGCTG 
ADORA3 TCGCTGTGGACCGATACTTGCG TAGAATGCACCCAGGGAGCCCA 
HMGN4 CCTCGGACGGCCACGAGAC TTCGCAGGTGGCTTGAGCAGT 
CCL4 GCTGCCTTCTGCTCTCCAGC AAAAGCAGCAGGCGGTGGGA 
TLR7 GCTCTGCTCTCTTCAACCAGACCT AGGAAACCATCTAGCCCCAAGGA 
HIF1A GCGGCGCGAACGACAAGAAA TCGCCGAGATCTGGCTGCAT 
DOCK10 GACAACGTTCCCTTGGAGCA CCACCTCCACTGTGGGTTCTGT 
      




Fkbp5 +65kb GCCAAGTTCAGCTGTGCAAT TGCCAGCCACATTCAGAACA 
Dusp1 -27kb GGCTTTGAGCTCACTTCCTG CTGGGTCCACTTTCCCACTA 
Actb promoter CTAGCCACGAGAGAGCGAAG CGCGAGCACAGCTTCTTT 
human     
FKBP5 +88kb TAACCACATCAAGCGAGCTG GCATGGTTTAGGGGTTCTTG 
PER1 +500bp CCAGGGGAAAAGGGAAGGTT TCAGCCCACTTCGGACTAGA 
ACTB 
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2.1.5 Single cell RT-qPCR 
 
This protocol uses the Cells Direct One-Step RT-PCR Kit (Invitrogen). 
Cells were harvested, resuspended in PBS and sorted into wells of a 96 well plate 
using a FACSAria (BD Biosciences) by Roslin Institute imaging services. Three 
wells received 1000 cells, three 100 cells and three 10 cells for reference. The rest of 
the wells received a single cell. Plates were immediately snap frozen on dry ice and 
stored at -80.  
To generate cDNA each well received: 5ul 2x reaction mix, 0.2ul Superscript III 
RT/Platinum Taq mix (with RNaseOUT Ribonuclease inhibitor), 2.5ul primer mix 
containing 20nM of each gene specific primer to be used in the downstream qRT-
PCR assays, 1.3ul nuclease free water (Ambion). The plate was then placed in a G-
Storm PCR machine and amplified using the following conditions: 50°C for 15 
minutes  (cell lysis  and reverse transcription), 95°C for 5 minutes (inactivates 
superscript and activates platinum Taq), followed by 22 amplification cycles of 95°C 
for 15 seconds , 60°C for 4 minutes. The resultant cDNA was stored at -20. 
 
2.1.6 3D DNA FISH 
 
2.1.6.1 Bacterial culture 
Genomic clones were supplied by BacPac Resources Centre at the Children’s 
Hospital Oakland Research Institute (http://bacpac.chori.org) . Fosmid clones are 
listed in Table 2.2. 
Bacteria from stab cultures or frozen glycerol stocks were streaked out onto LB agar 
to form single colonies and grown overnight at 37°C; cooled melted agar was 
supplemented with chloramphenicol 25ug/ml prior to being poured.  
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To prepare DNA a single colony was picked from an LB plate and used to inoculate 
5ml LB broth supplemented with chloramphenicol 12.5ug/ml. Cultures were then 
incubated with shaking at ~300rpm (InnOva 4230 incubator, New Brunswick 
Scientific) at 37°C overnight with a 5:1 air to liquid ratio. 
Table 2.2 Fosmid clones used for DNA FISH (co-ordinates from mm9 genome 
assembly). 
Locus Clone Chromosome Start End 
Fkbp5 WI1-1951C9 17 28621896 28660104 
 WI1-980F19 17 28504480 28545426 
Tmod1 WI1-2441L4 4 46121795 46162130 
 WI1-552C3 4 45995494 46038724 
Ms4xxx WI1-1714F1 19 11344410 11380699 
 WI1-2794B24 19 11607184 11647412  
 
2.1.6.2 Glycerol stocks  
Glycerol stocks of bacteria were prepared by adding glycerol to a concentration of 
40% v/v to 1ml of an overnight culture and stored frozen at -80°C 
2.1.6.3 Preparation of fosmid DNA from overnight culture 
Fosmid DNA was extracted using an alkaline-lysis miniprep. Approximately 3mL of 
cultures were pelleted at 16,000g for 30s then resuspended in GTE buffer (50mM 
glucose, 25mM Tris pH8, 10mM EDTA +10mg/ml lysozyme) for 5 minutes before 
addition of 400ul of ice cold lysis buffer (0.2M NaOH, 1% Sodium Dodecyl 
Sulphate) and incubation on ice for 5 minutes. 300ul of acetate buffer (3M potassium 
acetate, 11.5% glacial acetic acid (v/v)) was added, and the preparation incubated on 
ice for a further 5 minutes. The flocculent precipitate was centrifuged at 16,000g for 
5 minutes at 4°C and the clear supernatant was removed to a fresh eppendorf. 
Phenol:chloroform extraction was then performed by adding an equal volume of 
phenol-chloroform to the sample, centrifuging at 16,000g for 3 minutes, and 
removing the top layer. The DNA was precipitated with an equal volume of 
isopropanol and pelleted by centrifugation for 15 minutes at 4°C at 16,000g. The 
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DNA was washed with 70% ethanol, repelleted, resuspened in TE and stored at -
20°C. 
2.1.6.4 Labelling of fosmids 
Fosmids were labelled using biotinylated dTTP or digoygenin dUTP by nick 
translation. 500ng to 1ug of fosmid DNA was prepared as in section 2.1.6.3 and then 
incubated with 2ul Nick Translation Salts( 0.5M Tris pH 7.5, 0.1M MgSO4, 1mM 
DTT, 0.5mg/ml BSA fraction V (Sigma)), 1ul 1:20 DNaseI in ice cold dH20 
(Roche), 1ul T4 DNA Polymerase (Roche) 2.5ul each of dATP, dCTP, dGTP 
(0.5mM) and either 2.5ul biotin-16-dUTP (Roche) or 1.5ul digoxygenin-dUTP 
(Roche) and 1ul dTTP for biotin or digoxygenin labelling repsectively. The 
incubation was for 90 minutes in a 16°C waterbath. The reaction was stopped by 
adding 2ul 20% SDS and 3ul 0.5M EDTA and made up to 90ul with TE. It was then 
processed through a QuickSpin G50 sephadex column (Roche) as per manufacturers 
instructions.  
Effective labelling was detected using streptavidin-alkaline phosphatase or 
anti-digoxygenin alkaline phosphatase on nitrocellulose filters prepared by soaking 
in 20x Saline Sodium Citrate (per litre for 20x solution, NaCl 175.3g, Na3C6H5O7 
88.2g, prepared by MRC HGU technical services,  SSC) and then dried. Standard 
concentrations of biotin and dig labelled DNA were spotted onto filters alongside 4 
dilutions (1:500-1:10,000) of the prepared labelled DNA. This was then cross-linked 
onto the filter using 1500mJ UV irradiation in a UV500 cross-linker (Hoefer). The 
filter was washed briefly in 0.1M Tris pH7.5 0.15M NaCl then incubated for 
30minutes at 60°C in the same with Bovine Serum Albumin (Sigma) 3% (w/v). The 
filter was transferred to fresh buffer without BSA with the addition of 1% of the 
listed detectants above and incubated for 15minutes at room temperature. The filter 
was then washed twice in the same buffer then briefly in 0.1M Tris pH 9.5. The 
labelled DNA was detected using Vector Labs BCIP/NBT kit according to 
manufacturers instructions. Concentrations were assessed by comparison with the 
standards. 
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2.1.6.5 FISH procedure 
Slides prepared as described in section 2.1.2 were treated with RNaseA at 100mg/ml 
for 1hour at 37°C then washed in 2xSSC and dehydrated thorugh 70%, 90% and 
100% ethanol for 2 minutes each and air dried. Slides were then incubated for 5 
minutes at 70°C and denatured in 70% formamide in 2xSSC, pH 7.5, for 30 minutes 
at 85°C. Slides were then transferred to ice cold 70% ethanol, dehydrated as 
previously then air dried. 
80ng of labelled probe was used per slide, with 12µg Cot1 DNA (Invitrogen) and 
10µg sonicated salmon sperm, resuspended in hybridization mix (50% deionised 
formamide(v/v), 10% dextran sulphate (v/v), 1% Tween 20(v/v) in 2xSSC) and 
denatured at >70°C for 5 minutes. The probes were then pre-annealed at 37°C for 15 
minutes and hybridised to the prepared slides at 37°C in a humid chamber overnight. 
Slides were washed for 4x3 minutes in 2xSSC at 45°C, then 0.1xSSC at 60°C, then 
transferred to 4xSSC/1% Tween 20. Slides were incubatd for 5 minuted in 4xSSC, 
1% Marvel. Digoxygenin labelled probes were detected using FITC anti-dig Fab 
fragments raised in sheep(Roche) followed by FITC-conjugated anti-sheep(Vector). 
Biotin labelled probes were detected by Texas Red conjugated avidin(Vector), 
biotinylated avidin(Vector), then again  by Texas Red conjugated avidin. Each 
incubation was for 30 minutes. Slides were washed between each incubation for 3x2 
minutes in 4xSSC/1% Tween 20 at 37°C. A final wash was performed in 4xSSC/1% 
Tween 20 with DAPI 0.5µg/ml and slides were mounted in Vectashield. 
2.1.6.6 Image capture 
Images were captured using a Zeiss Axioplan 2 upright microscope with a PIFOC® 
collar for capture of z stacks. Acquisition and deconvolution of images was carried 
out using Volocity software (PerkinElmer). 
 
2.2 Data Analysis 
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Microarray and sequencing data have been deposited in GEO, series GSE61881 to be 
made publically available on publication of the associated research manuscript. 
2.2.1 Expression data 
Analysis was performed using R/Bioconductor packages ‘arrayQualityMetrics’, 
‘affy’ and ‘limma’ (Gautier et al., 2004; Kauffmann et al., 2009; Smyth, 2005). 
Expression values were generated using rma. Further exploratory expression analysis 
used unlogged expression values prefiltered for low expressed probesets as input for 
the graphical correlation based tool Biolayout Express3D  (Theocharidis et al., 2009). 
A range of correlation coefficients and MCL values was used to determine an 
optimal graph structure from which clusters of genes were then read. Clusters were 
then manually curated to remove artefacts. Genes from these lists were selected 
across a range of fold-changes for analysis by RT-qPCR as described above and a 
threshold drawn at log2 fold change where all tested genes were confirmed. To limit 
loss of genes with extreme profiles – and hence less likely to cluster - genes reaching 
log2 fold change >1.5 using a conventional analysis were also retained if the 
corresponding expression profile was consistent with a response across all replicates. 
Orthologues were identified using the HGNC Comparison of Orthology Predictions 
(HCOP) tool (Gray et al., 2013). 
2.2.2 Single cell PCR 
For each gene (Fkbp5, target; Gapdh, reference) the quantity of material present in 
each well of the cDNA plate was then assessed in triplicate across 3 different plates 
(e.g. for 2 genes and one 96 well cDNA plate this is therefore 6 x 96 well plates) 
using the Lightcycler 480 System and SYBR Green master mix (Roche). Wells from 
the cDNA plate that returned an inconsistent amplicon melting temperature or 
concentration. Analysis then correlated the relative amount of target vs reference for 
each well, normalising to the value given by material generated from 10 cells. 
2.2.3 Promoter Analysis 
Promoters were defined as -300, +100bp of the transcription start sites (TSS) 
recently described by the FANTOM5 consortium(Forrest et al., 2014). Where 
multiple TSSs are known, any overlaps were concatenated. Average sequence 
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conservation scores (phastCons) for promoter regions were extracted and enriched 
motifs identified using HOMER (Heinz et al., 2010).  
2.2.4 Comparison to GWAS results and inflammatory genes 
The GWAS catalogue (Hindorff et al., 2009) was accessed via 
http://www.genome.gov/gwastudies/ and manually edited to retain only hits with 
association to inflammatory / immune conditions ( including type II diabetes, 153 
unique SNPs) associations (1408 unique SNPs). The intersection of reported genes 
was assessed by fold change above a background distribution generated using 
permutation (100,000) of random gene sets. Significance of the difference was 
assessed using Pearson’s chi-squared test. The intersection of risk SNPs and 
promoters was ascertained using BEDtools (Quinlan and Hall, 2010).  
2.2.5 Functional Annotation 
Lists of functional terms from multiple publically available databases were generated 
using HOMER (Heinz et al., 2010), filtered using a threshold of –log p-value 6.5, 
then manually curated to remove duplicate terms.  
2.2.6 ChIP-sequencing  
Sequencing quality was assessed with FastQC(Andrews, 2010) and sequence from 
adapters removed using trimmomatic (Bolger et al., 2014). Paired end reads were 
aligned to mm9 or hg19 by Bowtie2 (Langmead and Salzberg, 2012) using default 
options (-D 15 -R 2 -L 22 -i S,1,1.15). Downstream analysis was performed using 
HOMER(Heinz et al., 2010), including creation of bedGraph files for visualization, 
peak calling and annotation. Peaks were celled by comparison with the sequenced 
input sample for each experiment as a measure of background. For the mBMDM 
data after confirming congruence (86% peak overlap), data from two independent 
replicates were combined. Publically available sequencing data for comparisons was 
accessed via NCBI GEO for Uhlenlaut et al (GSE31796) and Ostuni et al. 
(GSE38379).  
 The number of observed intersections of our GR bound sites with reported 
sites of PU.1 binding in unstimulated mBMDM from Ostuni et al. was compared to 
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to the median intersection that occurred in 1,000 genome permuted GR peak 
locations. Significance was assessed using Pearson’s chi squared test. 
To compare the locations of regulated genes with GR peaks the proportion of 
peaks within a given genomic interval of the TSS of a regulated gene was calculated. 
The enrichment of regulated genes with a GR peak was calculated as the ratio of the 
proportion of regulated genes that contained a GR peak within a given genomic 
interval to the proportion of regulated genes that did not contain a GR peak within 
the same interval. The significance of these results was estimated by comparing them 
to the 95% confidence interval of 1,000 replicates of genome permuted GR peak 
locations. These two analyses were performed with assistance from Robert Young, 
MRC HGU. 
2.2.7 Interspecies and evolutionary analysis 
The role of species-specific GR binding was assessed by counting the number 
of species-specific regulated genes with a bound peak within a 1Mb window of the 
TSS and comparing this to the number of genes with a bound peak within 1 Mb 
where only the orthologues in the alternate species was regulated in our data. Where 
multiple orthologues were present this analysis was run ‘all to all’. 
 Peaks were compared between species using liftOver provided by UCSC to 
get the coordinates of those peaks falling within syntenic blocks. Peaks with a greater 
than 25bp overlap were assigned as shared. To compare the enrichment of motifs in 
shared vs. aligned non-bound peaks we performed motif finding using HOMER as 
above, using the non-bound as background.  
 Insertions and deletions were called by comparison with dog (CanFam2), 
horse (EquCab2), cow (BosTau6) and pig (SuScr3) genomes If the sequence 
underlying a peak could be aligned to at least one of this species the peak was 
defined as being deleted, if not then it was called as a insertion. Human GR sites 
were assigned as deletions in mouse. 
  GERP scores for the locations of bound GR motifs in both human and mouse 
were extracted from the UCSC genome browser (Kent et al., 2002). These scores 
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have been calculated by running the GERP++ algorithm on the 36-way mammalian 
genome alignments (Davydov et al., 2010). 
Analyses in this section (2.2.7) were performed following discussion with and with 
assistance from Robert Young, MRC HGU. 
 
2.2.8 Analysis of 3D FISH data 
Deconvolved images (section 2.1.6.6) were analysed using Volocity software 
(PerkinElmer). For each image stack paired-probes within nuclei were manually 
identified by scrolling through the layers. The software then measured the distance 
between the probes. Nuclei with more than two pairs of probes or poorly resolved 
probes were excluded. The distance distributions were then compared using an 
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Chapter 3: The transcriptional response of 




As discussed in the introduction (Section 1.3.2), by contrast to other immune 
cells in the mouse, including B and T cells and classical dendritic cells, macrophages 
express high level of glucocortocoid receptors and are very sensitive to 
glucocorticoids (GC).  They are a major target for the anti-inflammatory actions of 
GC, accordingly, there have been previous studies of the transcriptional response to 
GC in a number of different cellular systems. However the data generated is not 
sufficient to draw integrated conclusions.  
In one study of mBMDM high dose (1uM) dexamethasone was used, the cells 
were starved of both serum and growth factor (CSF1) and the response was measured 
only at a single late time point (16 hours) (Uhlenhaut et al., 2013). A more recent 
study of mBMDM retained both serum and CSF1, but investigated only a single 
early time point (Chinenov et al., 2014). In humans single time point genome wide 
expression data for peripheral blood derived monocytes (PBMC) (Ehrchen et al., 
2007), PBMC differentiated with GM-CSF  and treated with high dose 
dexamethasone (Xue et al., 2014) or from PBMC treated with GC during 
differentiation (van de Garde et al., 2014) is available.  
The aim of the present study was to compare and contrast the responses of 
mouse and human macrophages to GC under comparable conditions. Inter species 
comparison of macrophages is not straightforward. The most common cell culture 
models of primary human and mouse macrophages are peripheral blood and bone 
marrow respectively, but they are not directly comparable. For example there are 
known species differences in the response to CSF1, which produces a proatherogenic 
signal in human macrophages (Irvine et al., 2009). Comparison between ostensibly 
more similar types does not necessarily provide the solution. Mouse monocyte 
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derived macrophages are only available in very small numbers, severely limiting the 
assays possible. They may also differ from human monocyte subsets in maturation 
and differentiation (Ingersoll et al., 2010). Human bone marrow derived myeloid 
cells can be obtained but do not behave as their mouse counterparts (Hume, 
Stephens, Warren, & Curtin, 1985). A previous report compared the responses of 
hMDM and mouse BMDM to LPS (Schroder et al., 2012) . The differences in LPS-
induced gene expression were clearly associated with promoter sequence variation, 
and the species-specific differences were confirmed in pigs, where both BMDM and 
MDM can be obtained readily.  In this respect, pigs are more similar to man at both 
the genomic sequence level and in their innate immune responses (Kapetanovic et 
al., 2012; Schroder et al., 2012).  Hence, the limitations of the cellular systems can 
partly be overcome if differences in transcription can be linked to differences in 
regulatory elements.  
  This chapter describes a comprehensive assessment of the response in both 
species using well-described and widely-used cell culture models, mBMDM and 
hMDM, as in the above previous comparative analysis (Schroder et al., 2012). 
Dexamethasone was chosen as the agonist for its high affinity for GR and relatively 
low affinity for the mineralocorticoid receptor (Lan et al., 1982).  Global gene 
expression was measured using microarrays at 6 time points over 24hours after 
treatment with dexamethasone 100nM, to identify both initial direct targets of GC 
and the downstream secondary consequences.   
 
3.2 The response of mouse bone marrow derived 
macrophages to dexamethasone 
 
Primary mBMDM were treated with 100nM dexamethasone and harvested after 0, 
1h, 2h, 4h, 10h, and 24h. RNA was extracted and analysed using industry standard 
Affymetrix expression arrays. From the raw expression data, after filtering for low-
expressed and low variance probes, lists of regulated transcripts were confirmed by 
Effects of glucocorticoids in macrophages 
The transcriptional response of macrophages to glucocorticoids 47 
RT-qPCR to produce a high confidence set of regulated transcripts (Figure 3.1 and 
methods). 264 induced and 102 repressed genes were identified and filtered to 160 
high confidence and validated induced and 50 repressed over the full 24h time series 
(Figure 3.2, full list in Appendix 1). Induced genes responded with faster kinetics: 
10%, 32% and 62% within 1, 2 and 4 hours respectively, compared to the repressed 
gene set (0%, 4% and 14% and the same time points). The robust induced gene set 
included several known GR targets Dusp1 (Tchen et al., 2010), Tsc22d3, Fkbp5 and 
Per1 (Reddy et al., 2009)). As expected from earlier studies of mBMDM (Hume and 
Gordon, 1984) the repressed gene list contains urokinase plasminogen activator 
(Plau) (Stacey et al., 1995). Since Plau is a target of sustained MAP kinase 
signalling (D’Alessio and Blasi, 2009), the repression may be an indirect 
consequence of the induction of the MAPK inhibitor Dusp1. Eight annotated 
transcription factors were amongst the induced gene set, including four (Fos, Hivep2, 
Klf4, Ncoa5) that were induced within 2 hours and that could contribute to the 
downstream regulatory cascade (Table 3.1). Functional annotation was not highly-
informative, with enrichment for nuclear processes, apoptosis and development in 
the early-induced set and cell surface immune response, phagocytosis, migration and 
cytoskeleton amongst the late responders. This is addressed further in section 3.4. In 
overview, a greater number of genes increase the amount of stable mRNA in 
response to GC than decrease, when measured in steady state mouse macrophages. A 
subset of these induced genes change rapidly (before 1h). 
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Figure 3.1 Validation and thresholding of microarray data. 
From the expression arrays genes were selected to represent a range of expression 
levels and time points to be tested using RT-qPCR. For early, mid and late time 
points examples of strong (>2 log fold change in the  expression microarray data) 
medium (~1 log fold change) and weak (~0.75 log fold change) responding genes 
were selected. Light red box represents the threshold value from the microarray data 
chosen for exclusion from downstream analysis. Error bars represent 2 x standard 
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Figure 3.2 Expression response over 24h of mBMDM to 100nM 
dexamethasone  
A Pearson correlation matrix was generated from the raw mBMDM microarray 
expression data, measured at 0, 1h, 2h, 4h, 10h, 24h. A graph was drawn using 
only those node-node relationships r>=0.89. Each node represents a probe set 
from the array and each edge represents a correlation. The graph was clustered 
using a MCL inflation value of 2.3 and each cluster assigned a different colour. 
Inset graphs show average expression profiles for the indicated clusters with 
representative gene symbols given. Light orange = induced, light blue = 
repressed.   
 
   
Table 3.1 Transcription factors regulated by 100nM dexamethasone in 
mBMDM 
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3.3 The response of human monocyte derived 
macrophages to dexamethasone 
 
Microarray analysis of the response of hMDM to GC identified 225 induced 
and 125 repressed genes meeting the filtration threshold (Figure 3.3 and Appendix 
2). As for mBMDM, the induced genes responded faster: 11, 30 and 70% changing 
within 1, 2 and 4 hours respectively (2, 14, and 47% for the repressed set at the same 
time points). Known glucocorticoid targets DUSP1, FKBP5, PER1 & TSC22D3 were 
induced by GC in the human cells, alongside the expected repression of PLAU. There 
were multiple transcription factors represented, ten induced and 4 repressed within 
2h (Table 3.2). 
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Figure 3.3 Expression response of hMDM to 100nM dexamethasone. 
A Pearson correlation matrix was generated from the raw mBMDM 
microarray expression data, measured at 0, 1h, 2h, 4h, 10h, 24h. A graph 
was drawn using only those node-node relationships r>=0.91. Each node 
represents a probe set from the array and each edge represents a correlation. 
The graph was clustered using a MCL inflation value of 2.0 and each cluster 
assigned a different colour. Inset graphs show average expression profiles 
for the indicated clusters with representative gene symbols given. Light 
orange = induced, light blue = repressed 
 
 
Table 3.2 Transcription factors regulated by 100nM dexamethasone in 
hMDM. 








NFIL3*  TCF7L2 
CEBPD* TEF 
MYC* HIVEP1 
GADD45A*  ELK1  FOXO1  HMGB2  THRB  ZBTB16  OLIG1  RUNX2   
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3.4  The expression response is different and is not 
linked to promoter variation  
 
Based upon the HGNC Comparison of Orthology Predictions tool (Gray et al., 
2013) there were 228 mouse orthologues for 225 GC-induced hMDM genes and 131 
orthologues for 125 repressed genes. The reciprocal analysis produced 157 human 
orthologues of 150 mBMDM induced and 55 orthologues of 50 mBMDM repressed 
genes.   From amongst this set of robustly-regulated genes, only 33 induced and 3 
repressed genes were shared by the two species (Figure 3.4A and Table 3.3). Genes 
regulated in the same way in both species genes were not regulated more strongly 
than the complete set for hMDM (median specific 1.8 vs. shared 2.0, p=0.07, 
Wilcoxon rank sum) although there was a slight difference in the case of mice 
(median 1.54 specific vs. 2.12 shared, p = 0.0009, Wilcoxon rank sum). There was 
also no difference in the time course of response for conserved genes; for hMDM 
15/51 (29%) genes induced early are shared compared to 38/226 (17%) of all 
induced genes (p=0.07, Pearson’s chi squared), the mBMDM equivalent figures are 
9/45 (20%) and 38/160 (24%) (p=0.74, Pearson’s chi squared).  
Comparison of the functional categories enriched in each species showed some 
differences. As stated above in mBMDM functional annotation of the induced genes 
showed enrichment for nuclear processes, apoptosis and development in the early-
induced set and cell surface immune response, phagocytosis, migration and 
cytoskeleton amongst the late responders. In hMDM there was substantial overlap in 
the terms. However, terms that were not found in mouse included adipogenesis, 
FOXO and insulin signalling, MAPK cascade, transcriptional misregulation in cancer 
and development. The immune pathways IL-10 production, NFκB, TNF, NOD-like 
receptor and rheumatoid arthritis were enriched in the hMDM-repressed set. Shared 
and differential terms are shown in Figure 3.5. 
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Figure 3.4 The expression response to dexamethasone is divergent despite promoter 
sequence conservation. 
A Intersections between regulated orthologues in mBMDM and hMDM. B Average 
promoter (-300,+100bp of TSS) sequence conservation scores (phastCons) for all 
shared genes and subsets of increasing GC responsiveness. All human promoters 
are shown as background (all hs). C&D promoter sequence conservation for all 
genes regulated in mBMDM and hMDM respectively, categorised by response and 
kinetics. All Refseq promoters shown as background. Conservation scores from 
phastCons. *** = p-value <1x10-10, ** = p-value <1x10-4, * = p-value <0.05, 
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Figure 3.5 Enriched functional annotation terms for the response of 
macrophages to dexamethasone. 
Multiple public databases of functional annotation were interrogated and 
significantly enriched terms are shown for induced (top), and repressed (bottom) 
gene sets. Data from mBMDM data are in yellow and hMDM in blue. Duplicate 
terms have been removed. All value terms shown are significant to at least -log p-
value > 6.5. * = Enriched in genes regulated 0-2h. Abbreviations: KEGG = Kyoto 
Encyclopedia of Genes and Genomes, GO = Gene Ontology, BP = Biological 
Process, MF = Molecular Function 
 
 
Table 3.3 Gene regulated in the same way in mBMDM and hMDM by 
dexamethasone 
Up     Down 
B3GNT5 FILIP1L MERTK PLAU 
CYTIP FKBP5 MMP19 IFIT1 
DDIT4 GLUL MS4A6A NR1D2 
DUSP1 TSC22D3 P2RY12   
FOS FPR1 PIK3IP1   
KLF4 GPR126 ZBTB16   
PER1 JDP2 MS4A4A   
SLA KLF9 P2RY13   
SSH2 LDLRAD3 THBS1   
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Many species-specific differences in LPS responsiveness of individual genes 
could be attributed to highly divergent promoters between mice and man (Schroder 
et al., 2012).  In GC regulated genes there was higher average promoter conservation 
when the GC target genes were regulated in both species (p-value = 1.32x10-5, 
Wilcoxon rank sum)  (Figure 3.4B) and for the genes in each species that responded 
most rapidly to GC (3.4C&D). However overall, despite their discordant regulation 
between the species, the promoter regions of all GC-inducible genes had relatively 
high sequence conservation (Figure 3.4C&D).   
Global conservation of sequence may not capture more subtle changes to 
information content within a given sequence. Specific motifs or regulatory elements 
may be gained or lost with only a marginal effect on the global conservation score 
but a substantial potential regulatory effect. To seek evidence of regulatory elements 
shared by GC-responsive genes in each species, the promoters (-300bp, +100bp of 
the TSS defined previously by CAGE analysis) (Forrest et al., 2014)  were scanned 
for motifs associated with transcription factor (Heinz et al., 2010).  Amongst the 
promoters of LPS-induced genes in both mouse and human there was clear 
enrichment for binding sites of many known inducible transcription factors, 
including NFkB and AP1 (Schroder et al., 2012).  These sites were not enriched at 
the promoters of GC-induced genes. Comparing to all RefSeq promoters matched for 
GC content there was also no evidence of any motif, such as the GRE, that might be 
implicated in direct GR binding at the promoters of the GC responsive genes.  
Considering all induced genes in mBMDM only the Cebpd motif met stringent 
identification criteria for enrichment (q<0.05, Benjamini-Hochberg). No motifs 
reached significant enrichment in the promoters of early-repressed genes whilst late 
repression was marginally associated with TATA-box (q = 0.052) and p300 
(q=0.057).  In hMDM, promoters of rapidly induced genes showed no motif 
enrichments, but there was an overrepresentation of E-Box and TATA-Box motifs 
(q=0.0469) in the promoters of genes with delayed induction in response to GC. 
Early repression was associated with NFkB-p65 (q=0.0006), NF1 half-site 
(q=0.0049) and TATA box (q=0.0337) whilst late returned FOXO1 (q=0.0065), 
SREBP1 (q=0.0123), and multiple ETS motifs, including PU.1 (q=0.0172) (Figure 
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3.6A&B). Promoters may be divided by presence or absence of increased density of 
CG dinucloetides (CpG islands), with CpG island promoters tending to be broader 
with more than one possible initiation site whilst sharp, non CpG island promoters 
tend to be more lineage specific (Illingworth and Bird, 2009). Looking for motif 
enrichment in GC regulated CpG island and non CpG island promoters separately for 
mBMDM showed no motifs reaching significance in the CpG set but enrichment for 
ETS motifs including PU.1 in the non-CpG set  (q=0.021 Benjamini-Hochberg, 2.1 
fold enrichment). In hMDM GC regulated genes with CpG island promoters also 
showed no significant motif signature, whilst the non-CpG promoters had enrichment 
for ETS motifs (q=0.0219 Benjamini-Hochberg, 2.7 fold enrichment). In summary, 
there was no evidence of a consistent promoter-binding factor at GC-responsive 
genes in either species although non-CpG island promoters may have more reliance 
on the lineage defining ETS factor PU.1, consistent with their role in more tissue 
specific genes (Illingworth and Bird, 2009).  
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Figure 3.6 Motifs over-represented in the promoters of dexamethasone 
regulated genes. 
The promoters (-300bp to +100bp) of the high confidence sets of GC-regulated 
genes in A hMDM and B  mBMDM were scanned for matches to known 





Promoter subset q-value Motif
Up mid-late 0.0469 Atoh1
Up mid-late 0.0469 Ebox factor
Up mid-late 0.0469 TATA Box
Down early 0.0006 NFkB-p65
Down early 0.0049 NF1-halfsite
Down early 0.0337 TATA Box
Down mid-late 0.0065 Foxo1
Down mid-late 0.0123 Srebp1a
Down mid-late 0.0172 PU.1(ETS)
Down mid-late 0.0372 SPDEF(ETS)
Down mid-late 0.0372 Smad3
Down mid-late 0.0372 PU.1-IRF(ETS:IRF)
Down mid-late 0.0372 PAX5
Down mid-late 0.0372 STAT6
Down mid-late 0.0372 MafA
Up (all) 0.046
Promoter subset q-value Motif
Motifs enriched in promoters of genes regulated in hMDM by dexamethasone






Down mid-late 0.051 TATA-box
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3.5 Targets of glucocorticoids in human 
macrophages enrich for risk variants for 
inflammatory disease 
 
Genes regulated by GC in human macrophages are candidates for involvement in 
inflammatory and metabolic disease and might therefore be implicated in genetic 
susceptibility. From the GWAS catalogue (www.ebi.ac.uk/gwas) I selected all loci 
with inflammatory or metabolic disease associations (1408 SNPs), including those 
defined as suggestive rather than fully genome wide significant in the original study.  
There was a significant enrichment: 48/350 GC regulated genes in hMDM have been 
reported to have an association with an inflammatory condition (3.7 fold over 
background, p=1.1x10-5, Pearson’s chi-squared, Table 3.4).  
Table 3.4 Intersection between dexamethasone regulated genes in hMDM and 
reported GWAS hits for inflammatory disease 
FOS$ SDC4$ TFCP2L1$ CXCL2$ TNF$
ITPKC$ SLAMF1$ SLC25A15$ ICAM1$ ZBTB46$
NFIL3$ SLC11A1$ MYC$ IL8$ TAGAP$
PAPOLG$ SLC15A2$ TNFAIP3$ NFKBIE$ SLAMF7$
GAB1$ TBC1D1$ MET$ NOD2$ CD48$
GRB10$ TMEM39A$ TMEM17$ ASRGL1$ ITGAL$
IL1R1$ C5$ SOCS1$ P2RX7$ IRF1$
MERTK$ IL1R2$ BCL11A$ SLC29A3$
!PPM1L$ RGS1$ CD83$ TLR7$




Of the SNPs associated with GC-regulated genes 14 did not reach full genome wide 
significance in the original study and 9 were not reported in main article (Table 3.5). 
A similar analysis considering the specific genomic loci demonstrated enrichment for 
SNPs with reported associations to inflammatory conditions in the region of induced 
genes (Figure 3.7). Only 3% (43/1387) of this subset of GWAS catalogue SNPs map 
to promoters and only one SNP maps to the promoter of a GC regulated gene 
(rs1738074, Coeliac disease, TAGAP, repressed).   
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Table 3.5 Weak GWAS hits regulated by GC in hMDM 
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Figure 3.7. Enrichment for SNPs with GWAS link to inflammatory disease near 
dexamethasone regulated genes. 
The incidence of SNPs that intersect with gene loci responsive to 
dexamethasone in hMDM for a range of windows surrounding the gene (red 
line). The 95% confidence limits for windows surrounding 10,000 permuted 






In both mouse and human macrophages there was a sequential cascade of gene 
regulation over 24h.  Although much of the literature on GC has focussed on 
transcriptional repression of inflammatory genes, the results highlight the fact that 
GC acts as a classical transcriptional activator.  The dominant response in both 
species was gene induction as measured at the level of steady state mRNA, and this 
response occurred more rapidly than repression.  The faster kinetics for induction is 
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consistent with previous work in A549 cells (derived from human lung epithelial 
cells) (Reddy et al., 2009).   In some cases, for example PLAU, the transcriptional 
repression may be a downstream consequence of gene induction (DUSP1). Whilst 
this was a non-stimulated setting rather than an inflammatory context, the 
reorganisation of the transcriptome measured here highlights the role of GC in 
macrophages beyond restraint of pro-inflammatory gene transcription. The approach 
taken here does not assess either loading of RNA polymerase or generation nascent 
transcripts so cannot capture a full picture regarding the initiation of transcription. It 
is inherent in this that for all but the least stable mRNAs repression will lag behind 
induction due to the lifespan of the mRNA already present. Given the translational 
output depends in some degree on the abundance of a mRNA this remains a 
reasonable comparison. A further limitation is I did not measure protein levels for 
these regulated genes so an additional layer of complexity lies above this response 
when considering cell function. 
A core set of known glucocorticoid targets was shared between the two 
models, but the vast majority were not.  The difference between the two species is 
even greater than that found in the inflammatory response to LPS, where the majority 
of target genes were regulated in a similar manner (Schroder et al., 2012). This is not 
necessarily surprising given the many differences between mice and man, but 
analysis of the local regulatory sequence does not provide an explanation as the 
promoters of these divergently responding genes are relatively conserved. Motif 
analysis did not find a common factor that binds to the promoters. There were some 
functional terms that are consistent with known human-mouse differences, for 
example roles in adipogenesis and insulin signalling enriched in the human data 
(Irvine et al., 2009; Stylianou et al., 2012). However given the limitations inherent in 
comparing these models discussed above there remains the possibility that some of 
this is cell type, not species difference. 
Human genes identified in this response have an association with inflammatory 
risk variants. Genome wide association studies identify candidate loci with a role in 
disease(The Wellcome Trust Case Control Consortium, 2007). In order to avoid 
emphasising false positives from this genome wide data stringent thresholds are used 
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that therefore discard many sites that may have a true biological link. The role of 
reported genes is often not clear in the context of disease and they are often simply 
the nearest to the SNP with the strongest association. The over-representation of 
reported genes in the hMDM GC responders reflects the intersecting roles of this cell 
type and stimulus and gives confidence that I have identified relevant targets using 
this model system. Conversely the data provide biological support to the previously 
identified targets, including some not reported as true hits initially due to relatively 
low significance (Table 3.5).   
3.7 Summary 
 
Transcriptional activation is the hallmark of the macrophage response to GC in both 
hMDM and mBMDM, however beyond a small core set the genes induced are not 
shared. This divergence is greater than that seen for classical pro-inflammatory 
stimuli and cannot be linked to promoter sequence changes. It is possible therefore 
that the differences between the culture models could be a contributor to this effect, 
rather than it being primarily species driven. 
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The primary mechanism by which glucocorticoids (GC) have their 
transcriptional effects is through binding to the glucocorticoid receptor (GR, gene 
symbol NR3C1). As discussed in section 1.1.2, GR is a nuclear hormone receptor 
that shares common domain structures with the androgen, estrogen, progesterone and 
mineralocorticoid (Figure 1.3) receptors. In the absence of GC, GR is held in the 
cytoplasm bound to chaperones including HSP70 and HSP90 and p23 (Oakley and 
Cidlowski, 2011). Ligand binding causes a dissociation of these and exposes a 
nuclear localisation signal thus allowing GR to enter the nucleus. Other factors such 
as the immunophilins FKBP51 and FKBP52 also bind GR at rest (Vandevyver et al., 
2012), these have a role in modulating the interaction of GR with both ligand and the 
major chaperones. By this mechanism these partners can regulate GC sensitivity 
(Jääskeläinen et al., 2011). 
 GR binds to an inverted repeat motif (AGAACAnnnTGTTCT)(discussed in 
section 1.1.2).  The absence of a consensus GRE motif at the promoters of GC-
inducible genes, and previous data in other systems placing GR binding away from 
promoters (John et al., 2008, 2011; Reddy et al., 2009; Uhlenhaut et al., 
2013),suggested that GR might induce transcription by binding to distal regulatory 
elements.  To determine the location of these elements, chromatin 
immunoprecipitation and sequencing (ChIP-seq) was performed using antibodies 
against GR, in mouse and human macrophages stimulated with dexamethasone. 
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4.2 GR binding in Mouse Bone Marrow Derived 
Macrophages 
 
One previous set of GR ChIP-seq data has been produced for glucocorticoid 
treated bone marrow macrophages (Uhlenhaut et al., 2013). However, the system 
used was not comparable. In the previous study the authors removed both serum and 
the macrophage growth factor CSF1 for 12 hours before the addition of 
dexamethasone.  They also used a substantially higher (1uM) concentration of 
dexamethasone and only very limited expression data was generated to pair with the 
receptor binding. Receptor binding in this study was assessed by ChIP-seq using 
M20 a polyclonal anti-GR antibody from Santa Cruz (sc-1004). It is known that the 
enhancer landscape of macrophages is defined by the conditions it experiences both 
at steady state (Gosselin et al., 2014; Lavin et al., 2014) and in response to stimuli 
(Ostuni et al., 2013). Therefore data on GR binding in response to GC in the same 
culture system used to generate the expression data presented in chapter 3 was 
required.  
Optimisation of this assay was challenging. Many ChIP-seq datasets for GR 
have used a cocktail of antibodies and a large amount of input material to gain good 
quality results (John et al., 2011). Figure 4.1 shows an example in which multiple 
antibodies and combinations of antibodies were screened for their ability to 
precipitate a known GRE  -4.6kb from the TSS of Dusp1 in standard ChIP-qPCR 
assays. GR ChIP-seq data was generated using a stringent protocol and the best 
performing antibody, which was a monoclonal (see methods). Here best performance 
was defined as the maximum signal at a positive locus (Dusp1 -4.6kb) compared to 
untreated for the same locus as well as a control site (ActB promoter) (Figure 4.1). 
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Figure 4.1 Optimisation of ChIP, example of antibody screening.  
ChIP-qPCR at a known GR bound ( Dusp1, -4.6kb from Dusp1 TSS) and a 
control (Actb, Actb promoter) locus. From left to right results from normal 
IgG, 2 different batches of a highly cited commercial antibody (M20, Santa 
Cruz), a mix of M20 and BuGR2 monoclonal (John et al., 2011) and the 
monoclonal BuGR2 alone. Results shown are from a single representative 
biological replicate; error bars are 2x standard error of the mean for 3 technical 
replicates. 
 
Figure 4.2 (A-D) shows representative UCSC browser tracks for measured 
GR binding in mBMDM.  Binding was observed in the vicinity of many inducible 
genes, regardless of their time course of responsiveness.  Examples are shown for 
genes induced by 1h (Fos), 2-4h (Jdp2), 2-10h (Fkbp5, Klf9), and at 24h (F13a1). 
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dexamethasone. These peaks lie away from promoters in intergenic regions and 
introns (Figure 4.3A).  
In the previous study noted above (Uhlenhaut et al., 2013), obtained by ChIP-
seq after cross-linking with both disuccinimidyl glutarate and formaldehyde, only 5% 
of the ~10,000 called ChIP-peaks had a consensus GR response element (GRE). 
Previous ChIP-seq data from cell lines have reported 50-62% of GR bound sites 
having a motif matching the GRE (John et al., 2008; Reddy et al., 2009). To assess 
the association between GR binding and motifs, a region of +/-25bp surrounding the 
peak maxima was examined.    Based upon de novo motif finding, the majority 
(78%) of our GR peaks contain a motif or motifs closely resembling the GRE at their 
centre (Figure 4.3B&C). The proportion of peaks with GRE rises further to 86% 
when considering a region +/-100bp from the peak centre (Figure 4.3D).  
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Figure 4.2 GR binding in dexamethasone treated mBMDM 
(A-D) Representative genome browser tracks for 3 induced loci, showing two 
early responders (0-2h, Fos, 2-4h Jdp2), two slower (2-10h, Fkbp5, Klf9) and 
one late responder (24h, F13a1). Data are for 100nM dexamethasone treated 
IP, vehicle IP and input. Genome co-ordinates are from mm9 assembly.  
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There is intersection with the previous data (Uhlenhaut et al., 2013) but 36% 
of the peaks in the current dataset, the vast majority of which contain a canonical 
GRE, are not present in their data. Peak score comparison between datasets is not 
straightforward. However, well-characterised GR peaks are present in both datasets 
with similar peak scores (e.g. Per1 -600bp 73.5 vs 58.7 Uhlenhaut et al. , Dusp1 -
27kb 200.9 vs 146.9 Uhlenhaut et al), the slightly higher values in our data are most 
likely due to different relative sequence depth and library complexity. Considering 
the unique peaks for each dataset those from my data are again, likely for the same 
reasons, slightly higher (median 11.4 vs 8.1, p-value = 1.33x10-15 Wilcoxon rank 
sum). Taken together this suggests that the differences between the datasets are not 
simply due to sensitivity.  
Gene repression driven from negative GRE (nGRE) has been reported to be a 
widespread phenomenon (Surjit et al., 2011). Although induction was the 
predominant response there were also many genes repressed therefore putative 
targets for nGRE mediated repression. However, de-novo motif analysis did not 
reveal any matches for the described nGRE (CTCC(n)0-2GGAGA, where (n)0-2 
indicates flexibility in spacing) (Hudson et al., 2013; Surjit et al., 2011). Scanning 
permissively specifically for motifs similar to this selects 59/488 peaks. Of these 
only 4 have a repressed gene within 1Mb (Plau, Egr2, Rgs2, Cy2s1), one of which 
has a prominent canonical GRE-containing peak at 74kb(Rgs2).  
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Figure 4.3 Characterisation of GR bound sites in mBMDM 
A Classification of regions bound by GR. B Enrichment for GRE in peaks 
found by ChIP-seq. C Motifs found de-novo +/- 25bp of the peak centre, D 
Motifs found de novo in region +/-100bp of the peak centre. 
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GR is known to act in concert with other factors (Altonsy et al., 2014; Rao et 
al., 2011; Ratman et al., 2013) and combinatorial binding is a feature of nuclear 
receptor and other transcription factor function at distal regulatory sites in 
macrophages (Glass and Ogawa, 2006; Heinz et al., 2010). Enhancers average ~200-
250bp in size (Andersson et al., 2014) and contain clusters of recognition sites for 
transcription factors. Other enriched motifs in the vicinity of mBMDM GR binding 
sites in this data include AP-1, Hif1b, Cepb and PU.1, (Figure 4.3D).  
 The ETS factor PU.1 is a master regulator of macrophage transcription 
(DeKoter and Singh, 2000; Natoli, 2010; Nerlov and Graf, 1998) and other stimulus 
induced transcription factors have been shown to bind at enhancers marked by PU.1 
in activated macrophages (Ghisletti et al., 2010; Heinz et al., 2010). Profiles of PU.1-
chromatin binding as well as active enhancer associated histone marks (H3K27ac, 
H3K4me1) and open chromatin have been published for non-stimulated mBMDM 
(Ostuni et al., 2013).  In the data presented here 94% of GR bound sites overlapped 
with at least one of the other baseline datasets, particularly PU.1 (72%). The majority 
overlapped more than 2 of these features (Figure 4.4). The sequence required for 
binding by PU.1, originally defined as 5’-GAGGAA-3’ (Klemsz et al., 1990),  is 
variable around a core now reported as GGAAGT embedded in a 12bp motif  (Heinz 
et al., 2013). The most specific consensus site may not be required for binding 
(Natoli et al., 2011), likely due to co-operation with other factors. PU.1 may require 
interaction with an alternate ETS factor (Ross et al., 1998) and in some cases can be 
substituted (Hoogenkamp et al., 2007).  Based upon a more permissive ETS motif, 
76% peaks of the GR bound sites were coincident with a potential PU.1 binding 
motif.  Amongst the 65% of GR bound sites with a consensus GRE, there was an 
average separation of 40bp between the two motifs.  Only 1.4% of peaks had neither 
GRE nor ETS motifs present. 
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Figure 4.4 GR bound sites in mBMDM overlap sites previously reported to bear 
marks associated with enhancers 
Comparison to published (Ostuni et al., 2013) data for marks found at 
enhancers (PU.1 binding, H3K4me1, H3K27ac, FAIRE-seq and H3K4me3). A 
Percentage of GR sites that overlap with the given features. Red bars indicate a 
GC matched genome permuted background set. B GR bound sites that overlap 
with the given number of listed features. 
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4.3 GR binding in Human Monocyte Derived 
Macrophages 
 
Due to the constraints on cell number when using subpopulations of human 
primary cells, as well as the virtual absence of binding in untreated mouse 
macrophages, ChIP-seq for GR was focused solely on dexamethasone treated 
hMDM. It is known that GR primarily resides in the cytoplasm in the non-stimulated 
state (Miranda et al., 2013), as confirmed above by the mouse data. Therefore the 
majority of GR bound sites identified here are likely to be acutely induced.  
Optimisation of the assay was again challenging. None of the antibodies that 
gave signal in mouse provided useful results in man for ChIP-qPCR, including the 
very efficient monoclonal used for ChIP-seq in mBMDM. However, after further 
antibody screening and alteration of assay conditions (see methods section 2.1.4) a 
ChIP-seq dataset comparable to that from mBMDM was obtained for hMDM. 
As in the mouse, there was evidence of GR binding in the vicinity of inducible 
genes, regardless of the time course of induction.  Representative browser images for 
the data are shown for peaks near genes regulated by 1h (PER1, DUSP1), 2-10h 
(FKBP5, PDK4), 10-24h (ADORA3, IL1R1, IL1R2) (Figure 4.5A-F). Using a 
stringent protocol in total there were 484 high confidence GR-binding peaks in 
dexamethasone stimulated hMDM. As in mBMDM, they lie away from promoters in 
non-coding regions of the genome (Figure 4.6A) and were highly enriched for a 
motif that closely matches the consensus GRE (52% within +/-25bp, 62% within +/-
100bp, Figure 4.6B). Other motifs present in the 200bp region surrounding each GR 
peak include PU.1 (34%), IRF4 and RXR (both 5%) (Figure 4.6C&D).  Using 
permissive criteria, as used for the mouse data above, the 34% with a strict PU.1 site 
increased to 62% of peaks containing any enriched ETS factor binding motif, 
including 70% of peaks with a GRE. The average separation was 43bp between ETS 
and GRE motifs where they were coincident (40bp in mouse), 18% of peaks did not 
contain either (1.4% in mouse).  
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GR binding sites are possible targets for disease-associated polymorphisms in 
inflammatory disease. None of the inflammatory SNPs identified in chapter 3 
(section 3.5) directly overlapped with GR bound peaks, although 2 lie within 350bp 
(rs10499197, near TNFAIP3 and linked to SLE and systemic sclerosis and 
rs12466022, linked to multiple sclerosis). The analysis was extended to include SNPs 
that are in significant linkage disequilibirum with reported risk SNPs, but this did not 
reveal any direct overlaps. Two  additional disease associated variants were located 
in the region of GR bound sites: rs403439 and rs 2743403. The first lies 264bp from 
a GR peak and is in LD with rs12984174, which is linked to asthma. The second lies 
468bp from a GR peak and is in LD with rs1008953 linked to psoriasis and lying 
adjacent to SDC4. Both of these alternative variants are common (allele frequencies 
~25%) so the regulatory significance of this is uncertain. 
Interestingly the GR bound peak adjacent to SDC4 is conserved from hMDM 
to mBMDM (Table 4.1). Sdc4 was weakly induced by dexamethasone in mBMDM 
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Figure 4.5 Genome wide binding of glucocorticoid receptor in hMDM 
Representative browser tracks for loci regulated within 1h A PER1, B 
DUSP1, 2-10h C FKBP5, D PDK4, and 10-24h E ADORA3, F IL1R2 & 
IL1R1 (IL1R1 responds 4-10h). Gene names in light grey are non-
regulated.  
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Figure 4.6 Characterisation of GR bound sites in hMDM 
A Classification of regions bound by GR. B Enrichment for GRE in peaks 
found by ChIP-seq. C Motifs found de-novo +/- 25bp of the peak centre, D 
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4.4 Glucocorticoid receptor binding is associated 
with induced, not repressed genes 
 
There was a clear association between GR binding peaks and GC-induced 
genes in both species, greatest at 10kb from the TSS, but still marginally detectable 
at 1Mb.  Conversely, there was no detectable relationship between GR-binding peaks 
and repressed genes (Figure 4.7A-D). Considered from a gene-centric view 77/160 
induced transcripts in mBMDM showed evidence of GR binding within 200kb of the 
TSS (105/160 within 1Mb), compared to only 1/50 that were repressed. The hMDM 
equivalent figures were 78/225 induced, 8/125 repressed within 200kb (159/225 
induced within 1Mb). There was no difference in the range of motifs found in peaks 
near early or late genes. From a peak-centric view 33% lay within 1Mb of an induced 
gene in mBMDM (32% in hMDM) and this subset of peaks had higher signal for GR 
binding than those more distant (mBMDM GR peaks <1Mb median peak score 18.8 
vs. 12.6 for > 1Mb, p=1.37x10-5; hMDM GR peaks <1Mb median peak score 28.5 
vs. 22.1 for >1Mb, p=0.0078, Wilcoxon rank sum). 
The expression response to GC was stronger where there were multiple GR 
peaks within 200kb of the TSS of an induced gene than if there was only a single GR 
bound site (mBMDM median log2 fold change 2.43 vs 1.43, p=0.0018, hMDM 
median log2 fold change 2.53 vs 1.76, p=0.031, Wilcoxon rank sum). Early (<2h) 
induction was not associated with greater peak proximity (mBMDM median distance 
22kb vs 46kb, p=0.199, hMDM median distance 46kb vs 88kb, p=0.162, Wilcoxon 
rank sum) nor was there a difference in peak strength. 
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Figure 4.7  Induced genes are associated with GR binding 
The proportion of peaks with induced (green) or repressed (red) genes 
within a given genomic interval for A mBMDM and B hMDM. The 95% 
confidence intervals from matched permuted distributions of GR peaks are 
shown in grey. The enrichment of the proportion of induced (green) genes 
with a GR peak within a given interval versus the proportion of induced 
genes without a GR peak within that interval for C mBMDM and D 
hMDM. No enrichment is seen for repressed genes (shown in red) The 
95% CI from a permuted distribution of GR peaks is shown in grey. This 
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4.5 Inter-species differences of glucocorticoid 
receptor binding are associated with sequence 
changes that lead to motif loss 
 
As noted in the introduction (section 1.4), turnover of enhancers has been linked to 
response divergence (Heinz et al., 2013; Stefflova et al., 2013). The landscape of 
enhancers is also different from mouse to man, particularly for immune genes 
(Stergachis et al., 2014; Yue et al., 2014). 
The GR bound sites from hMDM were intersected with those bound in 
mBMDM, limiting to regions of conserved synteny (using liftOver from UCSC 
(Kent et al., 2002)). Amongst the human dataset there were only 22 bound sites that 
were both conserved and within 1Mb of a regulated gene (Table 4.1).  Most of the 
GR bound sites could however be aligned between species (Figure 4.8). There was 
no difference between the rate of turnover between species (aligned sites vs. 
inserted/deleted sites) and as observed previously there was a minor deletion bias 
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Figure 4.8 Evolutionary outcomes for GR peaks in human. 
Aligned sites where the orthologous region is bound by GR in mouse are 
shown in green and in orange if the site is not bound by GR in mouse. Sites 
that could not be aligned are defined as either insertions (cya) or deletions 
(purple) by comparison with dog (CanFam2), horse (EquCab2), cow 
(BosTau6) and pig (SuScr3) genomes (see methods), Human GR sites were 
assigned as deletions in the mouse lineage. 
 
Of the shared sites (16) were adjacent to genes induced in both species and are 
known regulators of the inflammatory response (e.g. DUSP1, FKBP5 (Figure 
4.9A&B), MAP3K6, TSC22D3, FOS, KLF4,). Three of the others are adjacent to 
genes that are strongly regulated in hMDM but much less so in mBMDM, thus were 
filtered from the robust gene set used for comparisons (C1qb, Sdc4 and Mt2,Table 
4.1).  Even at the conserved loci GR binding differed: the previously described 
proximal peaks at the DUSP1/Dusp1 locus were retained (Tchen et al., 2010) but the 
strongest binding site was not shared (Figure 4.9A). Overall, genes which were 
upregulated in both species were enriched for having GR bound within 1 Mb in both 
species (4.0-fold enrichment, chi-squared p = 2.9x10-7 ; Figure 4.9A). 
The more common pattern was for GR binding to be divergent between the 
species; for example the GR peak upstream of F13a1, a component of the 
coagulation cascade, is mouse-specific (Figure 4.8C,). Mouse-specific GR binding 
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was more frequent in the region of genes that responded to GC only in mouse (2.0-
fold enrichment over human, chi-squared p = 0.0011; Figure 4.8D). Similarly, human 
specific GR binding was enriched adjacent to human specific GC responders, for 
example ADORA3, which has a known role in driving the human macrophage 
phenotype (Barczyk et al., 2010) has an intronic GR peak that is not present in the 
mouse data. As for the mouse data, there was an overall 1.7-fold enrichment for a 
human-only GR peak within 1Mb of genes that were specifically upregulated in 
human macrophages (chi-squared, p = 0.034; Figure 4.9E&F). 
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Figure 4.9  GR binding sites are minimally conserved between mouse and man 
and this is linked to the divergent transcriptional response to GC.  
(A) GR ChIP-seq data from mBMDM (orange) and hMDM (cyan) showing 
conserved GR binding (green highlight) at a locus (DUSP1/Dusp1) whose 
expression is rapidly induced by GC in both mouse and human macrophages. 
GR bound sites aligned between species are linked by light green highlight: the 
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most prominent sites are bound in only one species. (B) Enrichment / depletion 
for mouse/human shared GR binding within 1Mb for GC-responsive genes that 
are; shared between mouse and human (green), mouse-specific (cyan), human-
specific (orange). Numbers give raw counts for each category. (C) As in (A) 
but showing mouse-specific GR binding at F13a1/F13A1 which is induced in 
mBMDM but not hMDM. (D) As for B, but for mouse-specific GR binding 
sites. The chi squared p value for the difference between mouse and human 
specific sites is given.  (E) As in (A) but showing human-specific GR binding 
at ADORA3/Adora3 which is induced in hMDM but not mBMDM. (F) As for 
(D) but for human-specific GR-binding sites. 
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As discussed in the introduction the enhancer landscape is highly dynamic 
and is a function of the conditions studied (Gosselin et al., 2014; Lavin et al., 2014; 
Ostuni et al., 2013). Thus, since mBMDM and hMDM are not perfectly equivalent 
the differences found may be due to differences between the models. However if the 
Table 4.1 Conserved GR bound sites 
Human     Mouse     
Symbol Distance(bp) Peak Score Symbol Distance (bp) Peak Score 
MAP3K6 243 59.1 Map3k6 173 18.2 
DDIT4 18650 81.1 Ddit4 18152 15.4 
DDIT4 24921 166.4 Ddit4 22499 64.1 
ZBTB16 100510 33.5 Zbtb16 95679 16.1 
ZBTB16 119711 59.5 Zbtb16 112199 43.1 
MMP19 5101 18.9 Mmp19 11362 22.7 
FOS 62389 117.8 Fos 58829 65.7 
PER1 506 114 Per1 460 73.5 
PER1 2025 56.1 Per1 1885 47.4 
PIK3IP1 6071 37.7 Pik3ip1 5257 13.9 
DUSP1 4523 21.6 Dusp1 4261 18.8 
FKBP5 86865 37.9 Fkbp5 65828 79.9 
KLF9 66248 76.3 Klf9 84208 37.4 
KLF9 5346 24.9 Klf9 6120 13.3 
KLF4 271410 46.6 Klf4 209189 14.1 
TSC22D3 42816 49.9 Tsc22d3 37204 33.2 
Mouse orthologues are weakly regulated:   
 
  
C1QB 197 229.4 Map3k6 3645543 25.6 
- - - C1qb 174 25.6 
MT2A 1223 16.3 Ndrg4 1531461 6.2 
- - - Mt2 942 6.2 
SDC4 10723 75.8 Ncoa5 578851 33.8 
- - - Sdc4 13152 33.8 
Gene - peak relationships uncertain       
TIFAB 985838 15 Pdlim4 2152809 61 
TNFAIP3 159446 20 Sgk1 2695702 12.1 
ARG2 648524 27 Rab15 2811132 6.4 
 
Effects of glucocorticoids in macrophages 
Glucocorticoid receptor binding in macrophages 88 
differences are linked to sequence divergence then we can be more confident that this 
is a species difference 
Shared GR bound sites that aligned across species showed significant 
enrichment for the GRE motif when compared to those sites that could be aligned but 
did not have measureable GR binding in the other species (Figure 4.10A&B). This 
was also true for PU.1, although less strongly, reflecting the lower prevalence in the 
baseline dataset (Figure 4.10A&B). In the same way the frequency of the GRE was 
higher in the aligned sites that retained GR binding in both species compared to the 
aligned but unbound sites (human origin fold enrichment 3.4, p = 4.45x10-12, mouse 
origin fold enrichment 3.2, p= 2.44x10-12, Pearson’s chi-squared).  
Species-specific GR bound sites were strongly enriched for GRE compared to 
the sites that could be aligned from the other species but were not bound (Figure 
4.11A&B), with stronger enrichment for PU.1 in the mouse specific sites (Figure 
4.11A&B). Consistent with some retention of PU.1 at the mouse specific sites, there 
was a weak but detectable relationship between the non-bound mouse sites that could 
be aligned in human and human specific induced genes (Figure 4.11C-F).  Since 
most of the species-specific sites could be aligned (Figure 4.8) the changes that cause 
the motif loss are likely to be at the sequence level, such as nucleotide substitutions, 
rather than insertion or deletion of sequence. Overall this supports the hypothesis that 
these differences are due to species specific sequence changes, rather than being an 
artefact of the systems studied. 
If the differences outlined above were driven by host pathogen interactions, as 
suggested for LPS (Schroder et al., 2012), there would be an active loss of 
conservation, indicative of positive selection, beyond that seen for background. 
Conversely increased conservation is seen at sites of purifying selection; the loss of 
such sites is deleterious. Using per base evolutionary constraint (Davydov et al., 
2010) the shared sites in each species have increased constraint of the GRE (Figure 
4.10C&D), consistent with a conserved biology. However there was not a signature 
consistent with substantial purifying or positive selection across the motif at the 
species-specific sites (Figure 4.10C&D). 
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Figure 4.10 Conserved GR binding is linked to conservation of the GRE  
 
 (A) Motif enrichment for the sites bound by GR in mBMDM that aligned and 
were also bound in hMDM, using as background the sites that could be aligned 
but were not bound in hMDM (q values shown, Benjamini-Hochberg). (B) 
Analogous to (A) but for hMDM sites bound in mBMDM vs sites that could be 
aligned but were not bound in mBMDM. (C) Mean per base constraint scores 
calculated using GERP (Davydov et al., 2010) across the GRE in shared 
(green) and species-specific (red) peaks found in hMDM, where the grey bars 
represents the standard error of the mean. Vertical dashed lines delineate the 
centre NNN for the GRE, as derived de novo from our hMDM data. (D) 
Analogous to (C) for GR bound peaks and GRE motif found in mBMDM.  
Analysis performed with assistance from Rob Young, MRC HGU. 
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Figure 4.11 Loss of GRE motif is associated with species specific binding. 
A motifs enriched in the human specific peaks compared to the aligned mouse 
sites that are not bound by GR in hMDM. B motifs enriched in the mouse 
specific peaks compared to the aligned human sites that are not bound by GR 
in mBMDM. The proportion of peaks with induced (green) or repressed (red) 
genes within a given genomic interval for C mBMDM and D hMDM. Dashed 
lines represent peaks from mouse, which align in human, but are not bound in 
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hMDM. The 95% confidence intervals from matched permuted distributions of 
GR peaks are shown in grey. The enrichment of the proportion of induced 
(green) genes with a GR peak within a given interval versus the proportion of 
induced genes without a GR peak within that interval for E mBMDM and F 
hMDM. No enrichment is seen for repressed genes (shown in red). Dashed 
lines represent the same test performed using the peaks from mouse that align 
in human but are not bound by GR in hMDM. The 95% CI from a permuted 
distribution of GR peaks is shown in grey. Analysis performed with assistance 
from Rob Young, MRC HGU. 
 
Gene regulation occurs within a complex chromatin environment. A relatively 
stable higher order structure is proposed for the genome (Dixon et al., 2012) where 
interactions are relatively more likely within domains (topology associated domains, 
TAD). Regulatory interactions would then be enriched within these proposed 
topological domains. Comparison of the intervals between GR bound peaks and 
closest induced genes for each species shows no enrichment for the number of 
intervals contained within a single TAD vs randomly permuted intervals of the same 
size (hMDM 100/227 vs 109/227 p value = 0.45 Pearson’s chi-squared). As expected 
from the location analysis above (Figure 4.7), the peaks are significantly more likely 
to be in the same TAD as the nearest induced gene when compared to a random set 




The data have revealed GR bound enhancers in the region of genes induced by 
GC, but promoters are not bound. Many modes of binding have been proposed for 
GR (Nixon et al., 2013). However, in both human and mouse macrophages GR 
bound sites, as assayed by ChIP, were strongly enriched for DNA sequence motifs 
matching the canonical inverted-repeat GR dimer binding site (GRE).  
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Conservation has been suggested to be a predictor of GR binding at sites 
adjacent to regulated genes (So et al., 2008) and there was a small subset of sites that 
fit this pattern. However, the large majority of the GR bound enhancers and GR 
motifs were not conserved between mouse and man. This confirms the prediction 
from the recently published mouse ENCODE data (Yue et al., 2014) that distal 
regulatory divergence is strongest  for immunity. It is also consistent with previous 
work that shows variability of factor binding at distal sites can be a source of 
phenotype diversity between species (Villar et al., 2014) and this variation can 
accrue rapidly, even over the relatively short evolutionary distances between mouse 
strains (Stefflova et al., 2013).  
The gain or loss of GR bound sites was linked to sequence changes that cause 
gain or loss of the canonical GRE and partner motifs such as PU.1. This correlates 
closely with the species differences in transcriptional regulation described in the 
previous chapter. As discussed above, the cell models are not directly comparable. 
However, the fact that GR binding can be linked to DNA sequence changes between 
species suggests that the divergent expression response is not just an artefact of 
different culture models. Given the immune roles of macrophages and 
glucocorticoids relating to the immune response it is perhaps surprising that there 
was not evidence of pathogen driven positive selection underlying the divergence. 
The lack of apparent adaptive selection amongst lineage specific enhancers that drive 
gene expression is consistent with recent work in Drosophila (Arnold et al., 2014), 
although in that setting enhancer function more generally appeared to be relatively 
well conserved. 
Combinatorial binding of lineage determining and phenotype specific factors 
is known to play a critical role in macrophage biology (Glass and Ogawa, 2006; 
Heinz et al., 2010, 2013). For the GR response there was a role for PU.1 as there was 
a strong signal for both stringent and more lenient DNA motifs for this factor in the 
GR bound sites, along with majority overlap from previously reported PU.1 occupied 
sites (Ostuni et al., 2013). However the major motif that is gained or lost between 
species at species-specific GR bound sites is the GRE itself, with a weaker signal for 
PU.1. This indicates that whilst partner factors are important for GR binding, the 
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dominant effect remains within the GRE. This is in contrast to a study of human 
variants which lead to allelic imbalance where only a minority of differential 
transcription factor binding events found were associated with changes in the 
dominant motif. The majority were linked to subtler changes to motifs that were 
already more degenerate (Reddy et al., 2012). 
The exact mechanism by which distal elements regulate transcription remains 
to be determined (Pennacchio et al., 2013). Interaction, redundancy and co-
operativity for enhancers in a given locus have been proposed. For GR multiple 
bound sites have been associated with stronger gene regulation (Reddy et al., 2009). 
Macrophage GC targets also show this dose response relationship for GR binding, 
albeit weakly, which is supportive of an additive effect of multiple active distal 
regulatory elements (Section 4.4). 
GC have commonly been studied as repressors of inflammatory gene 
expression. In the context studied here GC act on macrophages primarily as inducers 
of gene expression, when measured at the level of stable mRNA.  As discussed 
above, the methodology does not address loading of RNA Polymerase, or initiation 
and elongation, which might be address by ChIP-seq and ‘global run on’ followed by 
sequencing respectively. The level of stable mRNA does however represent the 
complement of genes with detectable mRNA available for translation at any given 
time point, which remains a useful readout of gene regulation. The time series data 
revealed a cascade of gene regulation. Some of the later changes are likely to be 
secondary responses to the initial stimulus as explored recently for Klf4 (Chinenov et 
al., 2014). However, the late-induced genes were equally likely to have a GR bound 
peak in the region. These peaks were of the same strength and had the same range of 
associated transcription factor binding motifs. One explanation for the lack of 
correlation between binding and temporal profile is that GR binding is permissive in 
some locations, producing activation only in combination with other transcription 
factors that are induced earlier in the temporal cascade. 
Gene repression by GC was not associated with direct GR-DNA binding in 
either species. This is consistent with a report from candidate loci in cell lines (So et 
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al., 2008) and the finding of higher median distance between GR peaks and the 
nearest repressed vs. induced genes in the lung epithelial A549 cancer cell line 
(Reddy et al., 2009). Repression has been attributed by others to interaction with 
other chromatin-binding transcription factors rather than direct DNA binding DNA 
(Ratman et al., 2013). The difference in expression response between species was 
just as large for repressed as for induced genes. This is consistent with GR exerting 
its repressive effects by interacting with other factors bound at regulatory sites that 
are distant from promoters and evolving between the species.  There was no signal 
from secondary crosslinking between GR and other factors bound to such sites in the 
vicinity of repressed genes. The previous study by Uhlenhaut et al (Uhlenhaut et al., 
2013) used dual cross-linking with formaldehyde and disuccinimidyl glutaraldehdye 
in an explicit attempt to capture indirect interactions. This approach enabled them to 
report enrichment for motifs of known GR partners, but the large number and wide 
distribution of reported peaks prevented the assignment of any quantitative 
relationship with specific genes either induced or repressed by GC.   
Previous studies in other systems reported negative GR binding elements 
(Hudson et al., 2013; Surjit et al., 2011), but they were not present in either our 
mouse or human data. Lower binding affinity and faster turnover time could 
compromise their detection under the conditions employed here. Alternatively, there 
may be context dependent use of different types of regulatory element.  For example, 
the nGRE may only be relevant in macrophages when GR acts to suppress 
inflammatory gene induction, rather than in the basal CSF1-dependent state we 
examined (Uhlenhaut et al., 2013). An alternative mechanism that may underlie 
some of the repressive effects is secondary repression driven by the early-induced 
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4.7 Summary 
 
In keeping with more generalised mouse-human comparisons by the mouse 
ENCODE consortium (Cheng et al., 2014; Stergachis et al., 2014) the principles of 
the macrophage response to GC are strongly conserved between mouse and man. 
There are also a small number of loci where conservation can be found in both the 
regulatory architecture and expression response. At these sites it may be more likely 
that specific findings will translate well from mouse to man (and vice-versa).  
However, the extensive expression divergence that is attributable to sequence 
changes at distal regulatory sites, in combination with the profound differences in 
macrophage responses to LPS between mouse and human (Schroder et al., 2012), 
underline the caution that must be employed when attempting to directly translate 
many locus or pathway specific findings from mouse models to human medicine. 
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Chapter 5: Dynamic regulation of chromatin 




The data presented in chapters 3&4 confirm that in macrophages the majority of 
genomic sites bound by glucocorticoid receptor (GR) after treatment with 
dexamethasone lie away from promoters of regulated genes. It is also clear that GR 
binding is enriched in the vicinity of induced genes.  
The mechanisms of gene regulation from a distance remain uncertain  (section 
1.2.2) (Pennacchio et al., 2013). The data presented here and that by others (Reddy et 
al., 2009)  indicates that GR acts in this way, at least for gene activation, leaving 
open the question of how the effect is mediated.  
 Chromatin remodelling complexes are implicated in the regulation of a subset 
of genes by GR. Further, the pattern in which GR binds to DNA is defined by and 
then influences chromatin organisation (section 1.2.3) (Burd and Archer, 2013; John 
et al., 2011).  However, Hakim et al. did not observe large scale re-organisation of 
chromatin in response to GC (Hakim et al., 2011). Instead an increased frequency of 
pre-existing regulatory contacts is suggested (Hakim et al., 2011). A model 
consistent with this was presented for the GC responsive FKBP5 locus using 3C 
based techniques in A549 cells (Klengel et al., 2013; Paakinaho et al., 2010). In that 
study an increase in contacts between distal enhancers and the promoter was found 
on stimulation with GC. If GR works by increasing the frequency of dynamic loop 
formation between enhancer and promoter then it may be possible to identify this 
using 3D DNA FISH across responsive loci.  
Work on the kinetics of GR binding and loading of remodelling complexes 
suggests that conformational changes may be rapid, within minutes (Johnson et al., 
2008; Nagaich et al., 2004; Voss et al., 2011). More generally, local chromatin 
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dynamics have not been visualised after GC stimulation at native loci. It is not 
known to what extent measurable remodelling occurs at this scale and what role GR 
might play. The studies presented here begin to address this in the context of primary 
mouse macrophages. 
 
5.2 GR binding is associated with rapid and 
prolonged chromatin decompaction  
 
The genome wide expression and binding data outlined in chapters 3&4 identified 
regions of the genome that were both responsive to GC and bound by GR. From 
these loci, sites with strong binding and regulation were chosen for further 
investigation using 3D DNA FISH. The initial focus was a locus in which GR 
binding and inducible expression was highly conserved between mouse and man: 
Fkbp5. This gene produces a co-chaperone of GR in the cytoplasm and has known 
roles in feedback control and sensitivity to GC (section 1.1.2) (Jääskeläinen et al., 
2011), thus is also potentially of clinical interest.The gene locus and fosmid probes 
used to span the mouse Fkbp5 are shown in Figure 5.1. For comparison Tmod1, 
which was in the same expression profile cluster (Chapter 3, Figure 1.), but lacks the 
strong local GR binding peaks (Figure 5.2).. 
A detailed time series demonstrated by 3D DNA FISH that decompaction occurred 
across the Fkbp5 locus within 5 minutes of exposure of mBMDM to dexamethasone 
and was sustained to 24h (Figure 5.3A&B) By contrast, the distance across 
Tmod1increased with the same kinetics as transcription, reaching significance only at 
4h and then reducing towards baseline by 24h (Figure 5.3C&D). Since there was no 
apparent decline in the apparent decompaction after 24 hrs, the experiment was 
repeated with even longer treatment (Figure 5.4A).  In this experiment, across the 
Fkbp5, locus decompaction remained statistically significant after 5 days following a 
single dexamethasone treatment (Figure 5.4A). The prolonged change in 3D 
chromatin conformation was not dependent upon ongoing transcription. Expression 
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of Fkbp5 after 2h treatment followed by 22h in fresh culture media returns to close to 
baseline (Figure 5.4B)  
 
Figure 5.1 Location of fosmids used for 3D DNA FISH at Fkbp5 locus 
A Wide view of murine Fkbp5 locus. The position of the fosmid probes is shown as 
red and green boxes. ChIP-seq for GR is shown as tags/base pair. B Analogous to A 
but zoomed in on the gene to show finer detail. 
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Figure 5.2 Location of fosmid probes used for 3D DNA FISH at Tmod1  locus 
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Figure 5.2 Location of fosmid probes used for 3D DNA FISH at  Tmod1 locus 
A Wide view of murine Tmod1 locus. The position of the fosmid probes is shown as 
red and green boxes. ChIP-seq for GR is shown as tags/base pair. B Analogous to A 
but zoomed in on the gene to show finer detail. C Very wide view to show no GR 
bound within either of the two sets of TADs reported in (Dixon et al., 2012) using 
HindIII and NcolI restriction enzymes, TADs shown in black above locus. 
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Figure 5.3 Chromatin decompaction in response to glucocorticoids 
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Figure 5.3 Chromatin decompaction in response to glucocorticoids 
A Inter-probe distance measured across Fkbp5 locus after treatment  of mouse 
BMDM with 100nM dexamethasone for the indicated times as described in Methods 
(section). B Representative images of nuclei measured in A. Note the clear separation 
of the two probes on both loci in the treated cells , probes indicated by arrows. C&D 
Analogous to A&B but measured across Tmod1 locus for comparison. n = 80 for 
each dataset. Horizontal line = median; grey circles = data points; whiskers = 1.5x 
interquartile range; n= ~80 for each dataset;* = p<0.05, ** =p<0.005, ***=p<0.0005 
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Figure 5.4 Prolonged chromatin decompaction at Fkbp5 locus 
AInter-probe distance across the Fkbp5 locus in mBMDM stimulated with 
dexamethasone 100nM for the given times. Comparison is also shown with a vehicle 
treated sample that had been in culture for the same length of time. n=80 for each 
dataset. Dex = dexamethasone 100nM; -  = vehicle treated 48h; Median = horizontal 
black line; p values = Wilcoxon rank sum; whiskers are 1.5x interquartile range.B 
raw expression values for Fkbp5 over a 24h timeseries measured by microarray. 2w 
= treated for 2h with dexamethasone 100nM followed by replacing the media and 
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5.3 Rapid chromatin decompaction of Fkbp5 locus 
does not depend on transcription 
 
The rapid change in the structure of the Fkbp5locus precedes transcriptional output 
by an hour and it was therefore unlikely that active transcription was pre-requisite for 
the effect. The toxin α-amanitin causes a transcriptional block by irreversibly binding 
to the Rpb1 (Polr2a gene) subunit of RNA Polymerase II. Consistent with a 
transcription independent mechanism, pre-treatment of mBMDM with α-amanitin 
2.5ug/ml for 4 hours did not block the decompaction at Fkbp5, although it was 
marginally slowed, reaching statistical significance between 5 and 15 minutes 
treatment rather than by 5 minutes (Figure 5.5A&B). By contrast and as predicted, α-
amanitin ablated the chromatin changes across the Tmod1 locus (Figure 5.5C&D), 
consistent with a transcription dependent mechanism at this locus. This suggests that 
there may be a different, transcription independent, mechanism underlying the 
changes at Fkbp5. 
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Figure 5.5 Alpha-amanitin does not block rapid decompaction at Fkbp5 
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Figure 5.5Alpha-amanitin does not block rapid decompaction at Fkbp5 
A  Inter-probe distance measured across Fkbp5 locus after treatment with 
dexamethasone 100nM for the indicated times. B Representative images of nuclei 
measured in A. C&D Analogous to A&B but measured across Tmod1 locus for 
comparison. Horizontal line = median; grey circles = data points; whiskers = 1.5x 
interquartile range, n= 80 for each dataset; * = p<0.05, Wilcoxon rank sum; Dex = 
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5.4 GR binds rapidly at enhancers in the Fkbp5 locus 
 
The marked difference between the changes to chromatin architecture between the 
two loci discussed above suggested that the strong local GR peaks at Fkbp5, absent 
at Tmod1, may be involved. The ChIP-seq data was measured at 2h treatment. To 
confirm that GR bound on a timescale that would be consistent with a genomic role 
in the rapid effect, binding was measured at the upstream (-28kb), downstream (+65) 
and promoter by ChIP-qPCR for shorter time points.  Consistent with a direct role of 
binding, GR binding to the -28kb element was detectable within 5 minutes, and 
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Figure 5.6 Glucocorticoid receptor binding at Fkbp5 locus 
Glucocorticoid receptor binding measured by ChIP-qPCR for the downstream 
enhancer (+65kb), promoter and upstream enhancer (-28kb) of Fkbp5. Data is shown 
for a 4 point time series (baseline, 5min, 15min,1h) of treatment with 100nM 
dexamethasone. Normal IgG and a control site in the promoter of Actb (actb) is also 
shown. Error bars are 2xSEM for technical replicates, data is shown is one of two 
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The data presented above show the distal regulatory elements and promoters 
moving apart on activation, albeit that the resolution of DNA FISH is not sufficient 
to resolve the 28kb distance to the upstream element. This does not immediately fit 
with prevailing models that requires increased interaction of enhancers with 
promoters to induce transcription (Krivega and Dean, 2012). The models might be 
reconciled if a decompact state reflects greater freedom of movement, so that on 
average the decompact state is permissive to transient, activating, enhancer-promoter 
contacts. If this were the case, and the enhancer promoter interactions were of 
sufficient duration, one might see two populations of apparent inter-marker distance 
within the data, a smaller one with shorter distances, the other larger with longer. The 
smaller set may be insufficient to show in a single data set the relatively low 
throughput techniques employed here (n=80 for each time point). 
Pooling the total DNA FISH data for Fkbp5 in mBMDM yielded 245 
measurements for vehicle treated and 929 for dexamethasone treated cells. There was 
no detectable shift in the distribution to a bimodal pattern on treatment (Figure 5.7A), 
indeed the pattern of the distribution remained very similar (Pearson’s product 
moment correlation =0.93). Furthermore, analysis by single cell RT-qPCR did not 
show a subpopulation of responding cells (Figure 5.7B).  
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Figure 5.7 Characteristics of the response to dexamethasone at Fkbp5 
A Pooled measurements across the Fkbp5 locus for vehicle (blue, n=245) and 
dexamethasone treated (red, all time points included, n=929) mBMDM. B Relative 
expression level of Fkbp5 and Gapdh in single mBMDM cells. Values are 
normalized to measurements taken from 10 cells for each gene. If a specific sub-
population of cells respond to dexamethasone by disproportionately increasing 
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5.5 Rapid decompaction may be a feature of GR 
bound loci 
 
The locus studied above, Fkbp5, has a role in GC biology (section 1.1.2).  To 
determine whether the decompaction was a generalizable feature of GC-responsive 
loci, the same time series analysis was repeated at an alternate GR bound GC 
responsive locus. A site on chromosome 19 (chr19:11,551,990-11,673,273)had five 
regulated genes from a family of transmembrane proteins, with one major and one 
minor GR bound peak in the vicinity(Figure 5.8A). The expression response was 
slower than Fkbp5, sustained at 24h and two of the genes have significant activity at 
baseline (Figure 5.8B). 
Rapid decompaction was detectable across the locus after dexamethasone 
treatment (Figure 5.9A&B). As in the case of Fkbp5, decompaction clearly preceded 
gene induction (Figure 5.8B) despite the baseline activity and more decompact initial 
structure. As in the case of Fkbp5, and despite the baseline transcription, the effect of 
dexamethasone treatment was marginally slowed but not ablated by pre-treatment 
with α-amanitin (Figure 5.9C&D). 
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Figure 5.8 The site and response of a dexamethasone sensitive locus on 
chromosome 19 
A  UCSC browser image showing the locus. Shown are the genomic site, GR 
binding, regulated genes (highlighted, colours match to panel B) and the position of 
fosmid probes used for 3D DNA FISH (red and green boxes above track). B  Raw 
expression values for each of the regulated genes within the locus from the 
microarray time series reported in chapter 3. Colours match highlights in panel A. 
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Figure 5.9 Chromatin decompaction at a GR bound locus on mouse 
chromosome 19 
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Figure 5.9 Chromatin decompaction at a GR bound locus on mouse 
chromosome 19 
A  Inter-probe distance measured across chr19 locus illustrated in (Figure 5.8) after 
treatment of mBMDM with dexamethasone for the indicated times. B Representative 
images of nuclei measured in A showing the position of labelled fosmid probes 
flanking the locus detected using red and green fluorophores. C Inter-probe distance 
measured across chr19 locus after treatment with dexamethasone following pre-
treatment with alpha amanitin. D representative images of nuclei measured in C. 
Horizontal line = median; grey circles = data points; whiskers = 1.5x interquartile 
range, n=60 for each dataset; p-values as given, Wilcoxon rank sum; Dex = 




The data show that there are rapid changes to local chromatin structure around 
induced genes in response to GC in primary macrophages. This correlates with 
binding of GR and precedes the induction of transcription. The effect was not 
blocked by inhibiting transcription, therefore it is unlikely this effect is dependent on 
a transcribed eRNA (section 1.2.2.2). 
Dynamic exchange of transcription factors at regulatory sites has been 
proposed to be directly linked to chromatin remodelling (John et al., 2008). Nuclear 
hormone receptors bind rapidly and in a combinatorial fashion (Glass and Ogawa, 
2006; Métivier et al., 2003). Binding and turnover has been shown to be ATP 
dependent for GR (Stavreva et al., 2009). There is rapid recruitment of ATP utilising 
chromatin remodellers Brm and Brg1 to GREs (subunits of the SWI/SNF complex) 
within the GR responsive MMTV array (Johnson et al., 2008; Nagaich et al., 2004). 
The murine Fkbp5 locus specifically was one of many reported to be less responsive 
(reduced to 0.64x wild type) in a cell line engineered to have a dominant negative 
version of the ATP requiring remodeller Brg1 (John et al., 2011). 
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Directly linking the binding of GR to rapid decompaction is difficult. Absence 
of Brg1 did not ablate the transcriptional response, only restrained it to two thirds of 
wild type levels (John et al., 2011), so it is not specifically required. Unfortunately an 
attempt to assess Brg1 loading at the sites shown in (Figure 5.6) by ChIP-qPCR was 
uninformative, with very low and invariant signal at all sites and treatments (data not 
shown). The other loci studied here were not GC responsive in that system. 
The FKBP5 locus in humans has been examined specifically in two studies and 
is well conserved in mouse. The first used ChIP-qPCR in A549 cells and identified 
GR binding similar to that presented here and in chapter 4 (Paakinaho et al., 2010). 
They suggest that the Brm subunit of the SWI/SNF complex is required to achieve a 
full response (24 fold reduced to 12 fold induction by Brm knockdown). However 
they were not able to demonstrate recruitment of this complex to the enhancers on 
GC treatment. They suggest a role for CTCF and cohesin in formation of a putative 
loop containing the gene, consistent with growing literature implicating these factors 
in the regulatory organisation of the genome (Ong and Corces, 2014). In their model 
the loop then compacts further on activation; the opposite of what has been 
demonstrated directly here by 3D DNA FISH.  
Other studies in human cell lines have linked GR and BRM (Engel and 
Yamamoto, 2011). They showed that a subset of genes require BRM for full 
response and that GR binding may be reduced by BRM knockdown at the 
downstream FKBP5 enhancer. For other loci they find that there was reduced 
nuclease accessibility on GC treatment in BRM knockdown, but they do not study 
FKBP5. 
The FKBP5 locus is of specific interest in human disease susceptibility. Links 
between SNPs within the FKBP5 locus and multiple psychiatric diagnoses have been 
described(Binder, 2009). Further, specific risk SNPs and altered DNA methylation 
and chromatin conformation across the locus have been linked to higher risk of post 
traumatic stress disorder (Klengel et al., 2013). The association again is with 
increased enhancer-promoter contacts by 3C for the risk phenotype, suggested to 
increase the level of FKBP5 and hence alter the feedback control of the stress 
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response. The mechanism described is not certain since the methylation change 
reported is at a different enhancer to the risk allele, but the association of the SNP 
identified and primarily anxiety and depressive disorders appears robust. In this 
context the prolonged effect found in the present study (Figure 5.4) is of interest, as it 
hints at a structural change that can persist beyond the initial stimulus. This plasticity 
in chromatin may therefore be a contributor to prolonged effects following GC 
exposure and could have relevance to many areas of physiology and pathology 




For the loci studied there is an association between rapid decompaction of chromatin 
and GR binding. The mechanism of this is not clear but does not require 
transcription. Other studies have implicated ATP dependent chromatin remodellers 
in the response to GC, but without reference to the kinetics. The phenomenon occurs 
at but is not limited to a locus of clinical relevance in GC biology. Overall the 
findings are not easy to align with a model of increased enhancer-promoter 
interaction driving transcription, at least where these interactions are occurring in 
anything more than a tiny fraction of the cell population at a given moment. In fact 
the opposite, where GR binding appears to rapidly release constraint on a locus is 
more consistent with the data. 
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6.1.1 The genome wide response to GC in macrophages 
 
The work described in this thesis has demonstrated that GC act primarily as inducers 
of gene expression in primary macrophages from both mouse and man, but the set of 
induced genes is very different between the two species. GR bound to candidate 
enhancers in the vicinity of inducible genes that were generally not shared between 
mouse and man.   The differences in binding were correlated with DNA sequence 
changes at the enhancer sites between the two species, which caused gain or loss of 
predicted GR receptor-binding motifs within the enhancer.   
The inter-species divergence identified is striking, for both the GR binding 
and downstream expression response. However equally striking is the similarity in 
the pattern observed: both show binding at sites distant from promoters and enriched 
near induced genes. The data therefore argue strongly for the mouse as a model for 
understanding the principles of human, and specifically macrophage, biology. 
Concurrently it provides evidence for where (conserved loci) and where not 
(divergent loci) locus specific conclusions might be extrapolated more successfully 
between species.  
 
6.1.2 GC effects on chromatin organisation in macrophages 
 
The mechanism of action of GC was investigated by imaging several different target 
loci using labelled probes in macrophage nuclei.  The DNA at specific GC 
responsive loci increased the average spatial separation of probes flanking responsive 
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loci within minutes of exposure of macrophages to the ligand.  The apparent 
decondensation effect was maintained for at least 24 hours and was not prevented by 
inhibitors of transcription.  
6.2 Future work 
 
6.2.1 Enhancer turnover and variability 
 
The data indicate that the major change driving loss of GC response at induced genes 
between species is turnover of the GRE motif. Confirmation that the turnover of GR 
binding sites is the cause of the expression divergence could be achieved by re-
engineering a degenerate GRE, from a GR bound enhancer that aligns between 
species but is not bound. Improving the match to the GRE consensus motif in a 
stepwise base-by-base process should induce binding and cause induction of the 
target gene. If this re-engineering is not effective it may indicate that other elements 
such as PU.1 may also be required, albeit that GR appears dominant in the systems 
studied here.  Editing the genome in this manner could be achieved using, for 
example, the now widespread Clustered Regularly Interspaced Palindromic Repeats / 
Cas (CRISPR/Cas) system (Cong et al., 2013; Jinek et al., 2013). Transfection of 
primary mBMDM leads to activation (Stacey et al., 1996) and cell death (Roberts et 
al., 2009).  The murine macrophage like cell line RAW264.7 is GC responsive and 
can be transfected with less adverse effects (Stacey et al., 1996) thus could provide a 
model in which to attempt the recreation of a functional GRE. 
Studying an intermediate species would provide an alternate approach. Pig 
macrophages, both BMDM and MDM, can be grown using equivalent in vitro 
protocols to those used in this study and have been shown to be closer to human than 
mouse in response to LPS (Schroder et al., 2012). Expression and ChIP data from pig 
would be required to provide confirmation. Studying a conserved enhancer in human 
and pig that drives gene induction, that aligns but has lost the GRE and gene 
induction response in mouse, would support the hypothesis that it is the presence of a 
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consensus GRE that is causing the observed differences. The antibodies used for GR 
ChIP in mouse and man in this study did not work in the other species. It is possible 
therefore that GR ChIP in pigs may be challenging, although partly mitigated by the 
large numbers of cells readily available. 
This thesis has not attempted to address inter-individual variability between 
the human volunteers, as insufficient samples were included to draw valid 
conclusions. People differ in their response to GC and variability is present in the 
expression data, for example at CCL7 (Figure 6.1).  The data presented here predict 
that the difference will stem, at least in part, from genetic variation at regulatory sites 
(Heinz et al., 2013). The ideal study to address this would include a large number of 
individuals, as a meaningful effect size is difficult to estimate, and match expression 
and ChIP-seq data. There are practical limitations to this, in addition to the cost 
implications. The major issue is the challenge of generating ChIP-seq data for pure 
macrophages from a single individual within a reasonable donation of blood. To gain 
good data in this study, material from 4 volunteers was pooled. Therefore an average 
of the GR binding patterns for these individuals had been obtained. An alternative 
approach is that the identified sites could be used as candidate loci within which to 
search for variants using sequence capture technology and re-sequencing. Far less 
material is required for expression analysis therefore paired RNA samples from 
macrophages treated with GC could be obtained for comparison at loci where 
variants are identified. 
From a clinician’s perspective a key objective is to limit the side effects of 
glucocorticoid therapy (section 1.1.1,Table 1.1). Different GR ligands may cause 
altered GR binding by favouring a particular GR conformation. Exploring the GR 
binding pattern induced by novel ligands is an exciting avenue to increase 
understanding of how they may have differential effects on gene transcription. This 
is the focus of on-going work with collaborators (Dr. Ruth Andrew’s lab, BHF 
Centre for Cardiovascular Sciences, QMRI, University of Edinburgh). 
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Figure 6.1 Variability in expression of CCL7 in response to GC 
Expression values of CCL7 for, each individual volunteer’s monocyte derived 
macrophages, extracted from the microarray dataset presented in  section 3.3. Each 
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6.2.2  Kinetics of the macrophage response to GC and 
mechanisms of repression 
 
The data in chapter 4 show that late responding genes are equally likely to have a GR 
peak as early responding genes. Previous work has also shown that GR binding and 
transcription may not be simply correlated in time (John et al., 2009). GR dynamics 
are also critically affected by ligand choice. Dexamethasone has high affinity for GR, 
which has consequently prolonged association times compared to cortisol (in man) or 
corticosterone (in mice), which is likely to alter the dynamics of the global binding 
pattern. An ideal experiment to describe the response of macrophages to GC further 
would therefore have several time points with matched data from stimulation with 
multiple GR ligands; a non-trivial undertaking especially in the context of human 
primary cells.  
This study does not provide a mechanism for repression by GR, although 
some will be due to changes in the expressed transcription factor profile (Table 3.1, 
Table 3.2). Time series data for the histone modifications that are associated with 
poised and active enhancers (section 1.2.2.1) would provide additional insight into 
the nature of the regulatory landscape, as would a measure of chromatin accessibility 
such as DNaseI hypersensitivity. Transrepression by GR predicts that a set of 
regulatory sites associated with the repressed genes will exist that are not marked by 
direct GR binding, but have active histone marks such as H3K27ac and H3K4me1 
and are bound by other factors such as AP-1 (Ratman et al., 2013; Uhlenhaut et al., 
2013). Study of the position and sequence of these sites, if they exist, would shed 
light on the mechanisms by which GC repress.  
 
6.2.3 GC driven chromatin dynamics 
 
Rapid, transcription independent, decompaction is found at loci responding to GC 
that are bound by GR (section 5.2). Acetylation of histones can produce 
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decompaction (section 1.2.2). The histone acetyl-transferase p300 has been 
implicated in pulsatile association with GR at GRE (Conway-Campbell et al., 2011) 
and has been shown to co-immunoprecipitate with GR (Wang et al., 2012). High 
quality ChIP data for p300 across a candidate region such as Fkbp5, either by ChIP-
seq or ChIP followed by microarray (ChIP-chip), after dexamethasone treatment 
would determine whether p300 is dynamically recruited to the GR binding site, and 
whether the recruitment correlates with regulated histone aceylation in the vicinity of 
the bound GR.  Quality time series ChIP-seq or ChIP-chip data for Brg1 following 
dexamethasone treatment, would also be informative.  
 Knockout mice for both p300 / CBP and Brg1 exist but are embryonic lethal. 
The homozygotes also have substantial phenotypic abnormalities, particularly in the 
haematopoietic system, therefore are not ideal models for study (Blake et al., 2014). 
Small molecule inhibitors are available for both p300 and Brg1 but the effects would 
not be targeted to specific loci. The overall cell phenotype and chromatin 
environment would therefore be changed. 
To probe the mechanism further in a more specific manner it would be 
interesting to delete, individually and together, the enhancer elements and thereby 
establish whether they are required for both decompaction and the transcriptional 
response to GC. The decompaction detected in mBMDM at the Fkbp5 locus was 
recapitulated in the murine macrophage like cell line RAW264.7 treated with GC 
(Figure 6.2). Deletion of the enhancers in RAW264.7 cells, for example using the 
CRISPR/Cas system, could therefore serve as a model for this locus.  Another option 
would involve the use of CRISPRs to generate deletion of the control element in 
murine ES cells, followed by the production of macrophages in culture via the 
generation of embryoid bodies (Subramanian et al., 2009).  This approach is 
currently being tested in the Hume laboratory.  
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Figure 6.2 Rapid chromatin decompaction occurs in RAW264.7 cells 
Inter probe distance measured across Fkbp5 locus in RAW264.7 cells treated with 
dexamethasone 100nM for the indicated times.  
 
 
The role of GR at the enhancers could also be probed in the RAW264.7 cell 
model. Transcription Activator Like (TAL) effectors (Ding et al., 2013; Zhang et al., 
2011) fused to the activator VP64 can target and activate specific genes (Therizols et 
al., 2014). Recruiting domains of GR to the enhancers by fusing them to custom 
transcription factors which specifically target a single enhancer (Therizols et al., 
2014) would confirm that GR is required and might also identify the domains 
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involved at each site. Again, ChIP for potential partners such as p300 / CBP or 
Mediator subunits (section 1.2.2.1), under each different condition would begin to 
dissect the mechanism. 
Rapid decompaction can be produced by supercoiling, where twist is induced 
in the DNA helix by the passage of RNA polymerase II (Naughton et al., 2013; 
Villeponteau et al., 1984). Given the transcription independence of the GC response 
found in the present study supercoiling is an unlikely cause, but it could be tested. 
Bleomycin treatment induces DNA nicks thus relaxing the twisted formation 
(Naughton et al., 2013; Villeponteau and Martinson, 1987), which should then 
collapse any decompaction due to supercoiling.  
The results for Fkbp5 contradict previous findings by 3C in the human A549 
cell line, where the downstream element increased its interaction frequency with the 
gene promoter in response to GC (Paakinaho et al., 2010). A central question in long-
range control of gene expression is the nature of the interaction between regulatory 
sites and the genes they influence. Time series interaction data from mBMDM 
responding to GC using 3C may be highly informative and is a focus of current 
ongoing work. 
Prolonged changes in chromatin structure following a bolus of GC may be 
important (section 5.2). Dysregulation of the HPA axis in severe illness is linked to 
worse outcomes (Annane et al., 2009; Boonen et al., 2013). Severe illness is also 
linked to prolonged reductions in functional capacity (Lone and Walsh, 2012).  A 
stable change to the local organisation of GC responsive loci is therefore a candidate 
mechanism for involvement in the prolonged functional deficit. In the context of a 
prolonged response choice of ligand is important. This study used dexamethasone, 
which has a high affinity and long association time with GR (section  1.1.2). 
Comparison of the duration of effect after treatment with different GR ligands such 
as cortisol, which has a much shorter association time with GR, will be of interest. 
Further experiments might examine the compaction at Fkbp5 (a highly conserved 
locus) in various cell types for treated and untreated mice. Progress to human healthy 
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volunteer and patient studies would be feasible if mouse results were positive, given 




 The data presented in this thesis describes the transcriptional response of 
macrophages to GC in mice and humans and demonstrates significant differences 
between the two species. The differences in the majority of induced genes were 
linked to changes in the DNA sequence at regulatory enhancers located at a distance 
from the genes that change. Rapid and prolonged local decondensation of chromatin 
was found at GC sensitive loci in macrophages. 
Bridging the gap between fundamental mechanisms and physiological effects 
is the ultimate goal of my research. The data provide multiple exciting avenues for 
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Appendix 1 
This contains one entry for each gene regulated by dexamethasone 100nM 
in mBMDM 
logFC = log2 fold change, adj.p.val =  adjusted p value (Benjamini-
Hochberg) 
Time represents the point where the gene has its maximal change from 
baseline by lfc. 
     Official Gene Symbol logFC adj.p.val Time 
 F13a1 5.435155836 1.87E-16 24 
 Hp 4.599651578 2.06E-12 24 
 Pik3ip1 4.371279103 1.41E-12 10 
 Sult1a1 4.129464854 4.59E-12 10 
 Fkbp5 4.002554804 8.07E-13 10 
 Ddit4 3.979811626 2.94E-10 4 
 NA 3.954736843 1.34E-14 4 
 Ms4a6b 3.909149922 2.15E-11 24 
 Ms4a4b 3.856029719 5.25E-11 24 
 Lifr 3.647042737 1.20E-10 24 
 Zbtb16 3.49437474 1.38E-09 4 
 6030422H21Rik 3.485671443 7.59E-10 2 
 Prss16 3.477071823 1.24E-11 10 
 Dusp1 3.363805076 5.11E-11 1 
 Saa3 3.281105596 1.63E-13 24 
 Lyve1 3.204087271 7.58E-11 10 
 Cd55 3.022962191 1.46E-07 24 
 Ms4a4c 3.010537516 1.26E-07 24 
 Abhd15 2.962026041 7.41E-10 4 
 Rab15 2.854500771 3.98E-09 10 
 Sla 2.794717076 5.19E-13 4 
 Klf9 2.666514357 5.25E-11 24 
 Serpine2 2.664846017 1.00E-06 24 
 Filip1l 2.639129969 2.06E-12 24 
 Cbr2 2.623414223 7.49E-10 24 
 Tsc22d3 2.577505081 4.29E-15 4 
 Cd163 2.545715246 8.78E-11 24 
 Per1 2.540304193 4.41E-13 2 
 Thbs1 2.516264494 4.67E-08 24 
 Map3k6 2.444695128 6.36E-12 10 
 Marco 2.351556829 1.18E-08 24 
 Il15ra 2.32209633 1.71E-07 2 
 Gda 2.259680848 8.57E-10 24 
 Apoc2 2.240905265 7.39E-12 24 
 
Effects of glucocorticoids in macrophages 
Appendix 150 
Jdp2 2.235236381 1.92E-12 24 
 Sell 2.224631268 2.96E-08 24 
 Klhl6 2.212938786 1.67E-12 4 
 Mertk 2.124716056 2.08E-11 10 
 Ms4a6c 2.117456202 3.08E-10 24 
 Fam40b 2.112916033 2.94E-09 10 
 Cytip 2.094188592 2.38E-12 4 
 Fpr2 2.083019014 4.37E-06 24 
 Chi3l3 2.05894013 1.21E-07 24 
 Thbd 2.039018148 3.61E-10 4 
 B3gnt5 2.032204922 2.51E-06 4 
 Jag1 1.975272171 2.57E-05 4 
 Klf4 1.965627121 1.37E-09 2 
 Tlr8 1.948153802 3.62E-08 10 
 Gpr126 1.942767667 2.53E-07 4 
 Pex13 1.935376652 2.93E-12 4 
 Pla2g7 1.929061629 4.59E-09 24 
 AA409587 1.868530059 7.94E-08 2 
 Rnf169 1.863025622 2.38E-12 4 
 Lcn2 1.79704023 0.00017732 24 
 Lama3 1.792991339 2.43E-06 10 
 Ankrd29 1.786062972 1.83E-07 10 
 Fmnl2 1.779092813 2.40E-07 4 
 Ttc39c 1.770587156 1.32E-11 10 
 Pyhin1 1.765530256 4.56E-05 24 
 Nrg4 1.763219155 4.45E-08 24 
 Frmd4b 1.761710281 9.43E-09 24 
 P2ry12 1.758403183 1.52E-05 24 
 Maf 1.737816627 0.002025068 2 
 AA467197 1.690083178 2.12E-10 10 
 Stk17b 1.675291862 2.86E-11 24 
 Tmem37 1.668657246 9.63E-09 10 
 Ttpal 1.654378982 2.08E-07 4 
 Rffl 1.650638261 1.73E-06 4 
 4930523C07Rik 1.650597073 2.60E-07 24 
 Tns1 1.615814627 1.21E-09 10 
 A130040M12Rik 1.599548188 9.68E-08 4 
 Gpx3 1.599393721 3.66E-08 24 
 N4bp1 1.598411372 1.17E-08 10 
 Mmp8 1.588032995 3.58E-06 24 
 Samhd1 1.580359967 2.25E-05 2 
 Fpr1 1.575637582 1.99E-08 24 
 Chka 1.569628632 9.07E-07 2 
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Pstpip2 1.567613225 2.12E-05 10 
 Fhit 1.558985961 3.95E-06 24 
 Id1 1.549897704 0.000248871 24 
 Frat2 1.529601207 4.57E-05 4 
 Mgst2 1.527710059 1.53E-07 10 
 A130012E19Rik 1.516499445 0.017609868 2 
 Ogfrl1 1.515574597 1.71E-09 24 
 Ssh2 1.507675005 3.97E-09 4 
 Sik1 1.503465608 5.89E-07 2 
 Ccny 1.502090911 0.00070203 1 
 Rhoj 1.500088766 1.41E-06 10 
 Fabp4 1.496777089 0.031978093 2 
 Ap1s2 1.452176988 4.12E-05 2 
 Tlr7 1.451090517 2.28E-09 24 
 Foxred2 1.441950879 2.16E-09 10 
 Tigd2 1.409222107 9.89E-12 4 
 Glul 1.408643445 1.06E-09 10 
 Clec10a 1.398280949 2.15E-05 10 
 Fos 1.394439826 4.71E-05 4 
 Eps8 1.386235464 3.12E-11 10 
 Tmod1 1.38463195 4.98E-11 10 
 Dyrk3 1.383148147 8.70E-06 4 
 Sh3kbp1 1.372681511 3.21E-08 10 
 Klhl24 1.367227231 0.000157838 2 
 Ncoa5 1.356570992 7.28E-07 4 
 Acvr2a 1.345260941 1.44E-05 4 
 Ldlrad3 1.344645041 7.12E-06 24 
 Trp53inp1 1.341104072 1.82E-10 4 
 Ang 1.326696645 4.93E-09 24 
 Tcp11l2 1.326217601 1.28E-07 10 
 Mmp19 1.323751093 2.06E-07 10 
 Ptger2 1.300083043 1.63E-06 4 
 Aoah 1.28636391 0.001261189 24 
 Mlxip 1.280511165 8.81E-07 2 
 D930015E06Rik 1.278204166 8.01E-10 4 
 Rcsd1 1.275227282 1.53E-08 4 
 Gpr65 1.272778101 1.02E-08 4 
 Hivep2 1.254292168 4.55E-06 4 
 Wee1 1.24729766 1.50E-07 4 
 Il18rap 1.244413916 1.78E-05 10 
 Wnk1 1.242159407 0.011964331 4 
 Serinc3 1.224856774 9.78E-07 24 
 Cxcr4 1.223466803 3.37E-08 24 
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Mxd4 1.208626211 1.15E-07 10 
 Acss1 1.199777961 4.37E-08 4 
 Lyzl4 1.193382929 1.89E-06 24 
 Smurf2 1.191627743 8.09E-06 4 
 Ms4a6d 1.182134359 7.14E-10 24 
 Sgms1 1.180922805 4.82E-07 4 
 2210406H18Rik 1.165669127 2.01E-06 24 
 Tcf7l2 1.163752257 2.69E-07 4 
 Stxbp5 1.153607813 6.01E-05 24 
 Gab3 1.152348717 1.33E-07 4 
 Nedd9 1.144872474 1.53E-07 4 
 Ly6a 1.139359276 0.00943417 24 
 Bst1 1.11917443 9.46E-08 24 
 Gprc5b 1.107162284 3.46E-08 10 
 Tnks 1.099065979 0.000183217 4 
 Sgk1 1.0980162 3.61E-10 4 
 Tgfbi 1.091692315 1.85E-05 10 
 Peli2 1.074942073 7.67E-05 10 
 Rin3 1.073034378 7.26E-06 10 
 Adrb2 1.069024412 1.95E-07 4 
 Sqrdl 1.068701137 1.72E-08 10 
 P2ry13 1.066512991 1.47E-05 24 
 Fcna 1.066467547 4.92E-07 24 
 B3galnt1 1.045185998 5.72E-08 24 
 Stab1 1.045067906 2.21E-06 24 
 Usp2 1.044129785 0.000137044 4 
 Rnase4 1.042613479 2.93E-08 24 
 Phf15 1.034347654 7.76E-09 4 
 Dock10 1.025276734 2.74E-08 10 
 St14 1.02370349 0.001419124 24 
 Elmo2 1.023666512 0.001786397 10 
 Ypel5 1.020942933 8.14E-10 4 
 Glrx 1.02045127 4.50E-07 10 
 Man2a1 1.009025741 9.70E-09 24 
 Gng2 1.009019709 9.48E-06 24 
 Zc3h12c 1.008496066 3.00E-06 2 
 Mbnl3 1.008263897 0.010913661 24 
 Ckap4 1.005866077 0.00097655 4 
 Myo10 1.002623811 3.06E-07 10 
 Slc24a3 1.000212899 0.000102883 10 
 Nr1d2 -1.000532259 4.62E-09 10 
 Atp6v0a1 -1.01119555 3.58E-05 10 
 Gpr162 -1.014609578 0.000341237 10 
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Cdkn1c -1.019055366 0.03008497 10 
 Tmem158 -1.019588632 0.014093005 24 
 Ckb -1.027224432 4.76E-09 24 
 Clec2i -1.034643358 2.11E-05 10 
 Dio2 -1.049316288 0.009913706 24 
 Fam46c -1.049442686 1.84E-06 10 
 Ednrb -1.056092767 0.000396377 4 
 Ndrg4 -1.056118654 3.33E-06 24 
 Plk2 -1.058527911 0.006192991 2 
 Ccr5 -1.060748452 0.004550396 4 
 Pdgfa -1.068793081 6.72E-06 10 
 Enc1 -1.093687562 3.53E-06 4 
 Dusp4 -1.095287466 1.89E-06 24 
 Rapgef3 -1.095604435 3.89E-05 4 
 Ptchd1 -1.09680213 0.002138765 24 
 Pdlim4 -1.103989253 5.19E-07 10 
 Rgs2 -1.122039369 2.75E-05 10 
 Slc15a3 -1.123357517 5.58E-08 10 
 Mamdc2 -1.133274664 3.08E-06 24 
 Akap2 -1.141301103 1.20E-05 10 
 Olfm1 -1.146380321 1.07E-07 24 
 Ifit2 -1.146391556 0.006600447 10 
 Afp -1.152571716 9.44E-06 24 
 Cyp2s1 -1.155119822 0.017933157 24 
 Gpr176 -1.155999008 2.11E-05 10 
 Zranb3 -1.208161284 1.62E-06 24 
 Lat -1.235195696 2.27E-05 24 
 Tox2 -1.235564976 4.76E-08 24 
 Procr -1.247325483 1.48E-08 24 
 Ifit3 -1.254771345 0.012863893 10 
 Cd72 -1.286467411 4.22E-07 24 
 Kit -1.319484026 1.95E-05 24 
 Mmp13 -1.320981799 4.89E-05 24 
 Il1rn -1.327997128 0.00181262 24 
 Rsad2 -1.338134934 0.000880947 10 
 Ifit1 -1.353409644 0.002107779 10 
 H2-Aa -1.354965441 6.93E-05 24 
 Irg1 -1.479734796 5.43E-07 24 
 Plau -1.500286492 9.81E-05 10 
 Itgb3 -1.524604535 8.08E-05 24 
 Fcrls -1.529191421 8.35E-08 24 
 Pcp4l1 -1.540628793 4.12E-07 24 
 Clec7a -1.620584758 7.90E-07 10 
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Tubb2b -1.704978219 2.66E-07 10 
 Egr2 -1.914428385 0.000423715 10 
 Serpinb9b -1.990919488 1.36E-07 24 
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Appendix 2 
This contains one entry for each gene regulated by dexamethasone 100nM 
in hMDM 
logFC = log2 fold change, adj.p.val =  adjusted p value (Benjamini-
Hochberg) 
Time represents the point where the gene has its maximal change from 
baseline by lfc. 
! ! ! ! !Official!Gene!Symbol! logFC! adj.p.val! Time!
!THBS1! 6.011209305! 2.90EC10! 10!
!NA! 5.860788311! 2.47EC13! 4!
!PDK4! 5.576900738! 1.42EC05! 4!
!ZBTB16! 5.520246906! 7.97EC11! 4!
!ADAMTS2! 4.836201777! 4.52EC09! 24!
!ALOX15B! 4.487971798! 5.04EC08! 10!
!CSGALNACT1! 4.456692393! 2.21EC10! 10!
!PKP2! 4.25952153! 1.23EC09! 4!
!SPRY1! 3.876521772! 8.65EC08! 4!
!FBLN5! 3.865219421! 8.70EC07! 10!
!LHFP! 3.846029032! 3.92EC11! 10!
!FKBP5! 3.810817922! 2.99EC08! 4!
!SLC16A10! 3.618428074! 6.98EC05! 10!
!SRPX! 3.580319696! 0.002451263! 24!
!RGS1! 3.530196157! 0.000595165! 1!
!TPST1! 3.407762656! 2.65EC09! 10!
!TFCP2L1! 3.375479259! 1.54EC05! 10!
!CAMP! 3.33652724! 6.72EC07! 24!
!TFPI! 3.214769973! 1.35EC06! 10!
!DAAM2! 3.204361515! 2.25EC10! 24!
!TSC22D3! 3.170353709! 1.09EC11! 2!
!PER1! 3.15474706! 1.25EC13! 2!
!DUSP1! 3.137911717! 1.09EC11! 2!
!NHSL1! 3.097129116! 1.11EC10! 4!
!DDIT4! 2.999764261! 7.51EC13! 10!
!ST6GALNAC3! 2.964764017! 2.65EC09! 10!
!GRB10! 2.925126431! 7.30EC11! 10!
!PRKCH! 2.901474641! 2.68EC10! 4!
!RHOBTB3! 2.897045146! 1.51EC07! 4!
!TBC1D16! 2.869961149! 2.65EC09! 10!
!EBI3! 2.828475078! 6.67EC06! 24!
!IL1R2! 2.816837527! 2.62EC06! 24!
!FLT3! 2.812254981! 3.20EC07! 24!
!SAP30! 2.797419166! 4.08EC09! 10!
!
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SGMS2! 2.772752397! 1.16EC07! 4!
!TBC1D1! 2.761206378! 2.29EC10! 4!
!MT2A! 2.722036611! 0.000238207! 10!
!RBMS3! 2.708370442! 3.89EC08! 10!
!FRAT1! 2.627753621! 2.72EC10! 4!
!SH3PXD2B! 2.590721293! 4.70EC12! 4!
!NUDT16! 2.553557391! 4.03EC09! 10!
!USP53! 2.539109483! 5.01EC06! 4!
!KLF9! 2.537338629! 5.97EC11! 4!
!ADORA3! 2.53459692! 0.003175306! 24!
!GRAMD3! 2.50856061! 1.03EC07! 10!
!MDM2! 2.500403017! 3.76EC10! 4!
!PLEKHA7! 2.497428525! 3.20EC07! 4!
!CNIH4! 2.462674729! 3.02EC08! 4!
!CD163! 2.428398187! 3.48EC07! 10!
!CRISPLD2! 2.415055036! 0.004001197! 24!
!TMCC3! 2.399492446! 7.85EC05! 2!
!MTMR11! 2.38161627! 6.05EC06! 4!
!PKIB! 2.380442458! 3.03EC06! 10!
!FOS! 2.373397158! 2.42EC10! 4!
!PTX3! 2.369402551! 8.59EC05! 10!
!PHF17! 2.365408241! 1.09EC11! 2!
!LDLRAD3! 2.36402155! 3.34EC06! 10!
!PCYOX1L! 2.350852707! 0.000204655! 10!
!DUSP4! 2.337580771! 0.000628178! 4!
!SESN1! 2.329288415! 1.15EC11! 10!
!MAN1A1! 2.327313791! 9.19EC10! 24!
!FAM117B! 2.313578863! 4.47EC06! 4!
!FMN1! 2.289455077! 9.77EC06! 4!
!CYFIP2! 2.287260459! 0.000339764! 10!
!GADD45B! 2.22349637! 9.83EC08! 2!
!PRKCE! 2.195454054! 2.39EC10! 10!
!GLDN! 2.192955986! 0.008999155! 24!
!SLC16A6! 2.16605694! 0.001349284! 10!
!SRGAP1! 2.165082352! 8.70EC07! 4!
!RBP7! 2.165050126! 1.17EC05! 10!
!MEGF9! 2.143498887! 2.12EC07! 4!
!CPM! 2.137981203! 3.83EC10! 10!
!MT1X! 2.127942411! 0.001502375! 10!
!MERTK! 2.118218316! 3.42EC12! 4!
!C5orf62! 2.101832849! 6.11EC14! 4!
!MT1P2! 2.10148216! 0.004874976! 10!
!C19orf59! 2.096129218! 5.20EC07! 24!
!
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CCNA1! 2.063152723! 0.004439186! 4!
!GPR126! 2.061674601! 0.000416505! 10!
!ISG20! 2.060295238! 4.12EC05! 10!
!PAPOLG! 2.057912252! 7.94EC09! 4!
!ZCCHC6! 2.035393876! 3.15EC10! 10!
!THRB! 2.033081186! 0.000273633! 10!
!P2RY13! 2.022155736! 0.000702702! 4!
!BLM! 2.019030261! 0.000110565! 10!
!CYTIP! 2.014133687! 2.26EC08! 2!
!KCNE1! 2.013014064! 0.048004236! 10!
!GLUL! 1.990465351! 4.73EC05! 10!
!SHOX2! 1.970106234! 1.38EC05! 4!
!KLF4! 1.954949187! 1.05EC05! 4!
!SLAMF1! 1.925165676! 0.003449345! 4!
!SLITRK4! 1.924140704! 0.004077529! 4!
!APCDD1! 1.91586443! 7.96EC08! 10!
!PALD1! 1.908224705! 0.000784953! 10!
!MMP19! 1.907484294! 0.001507136! 10!
!NFIL3! 1.890152977! 2.50EC09! 2!
!IL1R1! 1.887164105! 7.01EC06! 10!
!KCNJ2! 1.886561006! 8.66EC06! 4!
!P2RY12! 1.868120995! 0.005509819! 24!
!KIAA0146! 1.865449078! 5.22EC07! 1!
!LONRF1! 1.855378347! 1.41EC07! 2!
!LOC285812! 1.846725377! 2.06EC05! 4!
!SLC25A15! 1.846167577! 0.000128556! 4!
!PGRMC2! 1.844929779! 8.88EC05! 10!
!LRRC16A! 1.844048532! 0.000172003! 10!
!FILIP1L! 1.841723799! 9.73EC05! 4!
!PPARGC1A! 1.829195341! 0.003071635! 24!
!RNF144B! 1.821808551! 4.26EC05! 2!
!NAV2! 1.820198826! 0.019163574! 10!
!VCAN! 1.816167791! 1.45EC06! 10!
!CEBPD! 1.805750432! 1.72EC05! 1!
!CTTNBP2! 1.803414835! 0.001972932! 10!
!GAB1! 1.798258614! 6.26EC08! 4!
!TSPAN2! 1.790855265! 0.037854712! 10!
!FAM59A! 1.788293916! 7.51EC06! 4!
!B3GNT5! 1.779217192! 5.80EC11! 4!
!SEMA3C! 1.772648955! 0.00033442! 10!
!FPR1! 1.771500198! 5.51EC05! 10!
!SLC22A16! 1.771090196! 0.030365095! 10!
!CLEC4E! 1.769994058! 0.001593079! 10!
!
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SHMT1! 1.753889709! 2.22EC07! 10!
!VSIG4! 1.752602984! 0.000310521! 24!
!C10orf54! 1.749834302! 1.48EC06! 10!
!LINC00341! 1.74795307! 1.02EC06! 4!
!FCAR! 1.734375837! 1.10EC05! 4!
!MYC! 1.727880154! 5.70EC10! 1!
!GPR82! 1.722568696! 3.20EC05! 10!
!ITPKC! 1.720594744! 9.83EC08! 2!
!SLC25A37! 1.71190505! 1.76EC05! 4!
!CDKN1C! 1.711525375! 0.000683609! 24!
!S100A8! 1.710557418! 0.005682313! 24!
!ATAD2! 1.705410863! 1.64EC06! 4!
!IRAK3! 1.699302777! 1.08EC08! 10!
!GADD45A! 1.686298253! 0.046881195! 2!
!SLC38A1! 1.683268886! 0.001249891! 10!
!TNFRSF21! 1.683089982! 4.37EC08! 10!
!TNFRSF11A! 1.676791939! 6.63EC05! 10!
!KIF13B! 1.675137688! 4.61EC11! 4!
!ZNF189! 1.666159052! 3.11EC05! 2!
!ADM! 1.664014379! 2.10EC06! 1!
!PIK3IP1! 1.663919989! 3.15EC08! 10!
!KLF7! 1.663855874! 1.56EC05! 2!
!SSH2! 1.652178798! 5.45EC09! 4!
!MT1F! 1.626635757! 0.001439376! 10!
!OLIG1! 1.625107843! 0.005615405! 24!
!LOC729680! 1.622592474! 0.000319066! 10!
!RCAN1! 1.618555922! 0.000690268! 10!
!TNFAIP3! 1.613243138! 1.17EC05! 1!
!GFOD1! 1.594779062! 3.84EC05! 4!
!MET! 1.590858534! 1.19EC06! 10!
!TMEM17! 1.590565717! 2.81EC06! 4!
!CALCRL! 1.5890609! 0.000126495! 10!
!WDR63! 1.587050056! 3.24EC05! 4!
!MS4A6A! 1.584745269! 0.002329683! 4!
!ORMDL1! 1.583163967! 1.21EC05! 10!
!TMEM198B! 1.57384955! 2.63EC07! 10!
!GCLC! 1.573170983! 9.62EC05! 4!
!RUNX2! 1.571783948! 0.030626315! 4!
!SLC15A2! 1.568017019! 0.005617312! 10!
!ERLIN1! 1.565093068! 0.000345688! 4!
!SRGAP2C! 1.563863929! 1.47EC07! 4!
!GNB5! 1.559097321! 1.64EC05! 10!
!ARRDC3! 1.55556886! 7.21EC08! 1!
!
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SOCS1! 1.549099457! 1.85EC05! 4!
!ALCAM! 1.549028576! 3.23EC05! 10!
!YPEL2! 1.548345991! 3.19EC05! 4!
!OGFRL1! 1.542016732! 8.45EC08! 4!
!PSTPIP2! 1.540792943! 1.57EC05! 4!
!PPM1L! 1.535734209! 0.000145678! 10!
!CD72! 1.530468303! 5.56EC05! 10!
!IRS2! 1.527573415! 9.42EC11! 10!
!TXNIP! 1.525897445! 0.000171486! 10!
!INSR! 1.521014859! 0.000186497! 10!
!ABLIM3! 1.51504739! 0.001582473! 10!
!SLC19A2! 1.514207595! 1.39EC05! 2!
!TBC1D8! 1.511054435! 4.08EC05! 10!
!ALDH1L2! 1.500985653! 2.99EC05! 10!
!PSME4! 1.500335467! 7.58EC05! 4!
!METTL7A! 1.48689094! 2.36EC07! 24!
!EZR! 1.46212862! 0.000454978! 10!
!SRGAP2! 1.43487271! 7.10EC08! 4!
!MS4A4A! 1.432577545! 9.00EC05! 10!
!ECHDC3! 1.42583698! 1.90EC08! 10!
!ELK1! 1.417121679! 6.07EC06! 4!
!SLC11A1! 1.401803322! 0.001963584! 10!
!ACSL1! 1.371622812! 1.28EC07! 4!
!MTMR4! 1.363521359! 3.46EC07! 4!
!C5! 1.352097478! 0.000501407! 24!
!FOXO1! 1.340757809! 6.67EC05! 4!
!IL13RA1! 1.331423726! 1.96EC07! 10!
!SLA! 1.329050898! 7.07EC09! 4!
!GRAMD1B! 1.327926444! 0.0001498! 10!
!C1QB! 1.312287499! 0.000138508! 24!
!SLC31A2! 1.307859569! 5.42EC09! 4!
!PTEN! 1.292599145! 4.21EC08! 10!
!FAM100B! 1.279235041! 1.15EC08! 4!
!HMGB2! 1.273309156! 6.18EC09! 10!
!SPTLC2! 1.26879127! 2.90EC08! 4!
!PHC2! 1.253422701! 7.43EC10! 4!
!PMS1! 1.252198464! 6.17EC07! 10!
!MAP3K6! 1.236628026! 0.00178247! 10!
!HIPK2! 1.225602838! 4.03EC07! 10!
!ZBTB8A! 1.215650994! 0.004564297! 10!
!MCL1! 1.210648563! 5.69EC07! 4!
!SH3BP5! 1.207415905! 0.000501368! 4!
!FRMD4A! 1.175251398! 0.002002282! 4!
!
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SMAP2! 1.165033849! 6.38EC08! 4!
!CLN8! 1.150329348! 0.002706623! 4!
!KLHL8! 1.14380126! 2.12EC07! 4!
!GPR34! 1.143705519! 5.97EC07! 10!
!ENOX2! 1.119867864! 0.000229518! 10!
!TMEM39A! 1.113677954! 0.000697014! 4!
!SDC4! 1.109329708! 2.25EC05! 10!
!FAR2! 1.108694009! 1.82EC06! 10!
!TP53BP2! 1.09455046! 9.73EC09! 2!
!MTSS1! 1.09037403! 0.003286841! 10!
!FGD4! 1.073698059! 1.93EC06! 4!
!TOP1! 1.060702469! 8.50EC08! 4!
!DISP1! 1.058189086! 0.002695905! 10!
!FOXN2! 1.057143584! 2.70EC06! 4!
!TLR2! 1.054146997! 6.21EC06! 4!
!SETMAR! 1.038860033! 1.59EC05! 4!
!FOXO3! 1.019263123! 3.07EC08! 4!
!JDP2! 1.014392814! 1.79EC08! 10!
!TCF4! C1.003287912! 1.38EC06! 4!
!FMNL3! C1.003908606! 0.008225375! 24!
!MYO9B! C1.005273326! 1.23EC07! 10!
!ICAM1! C1.007942338! 2.60EC06! 10!
!BLNK! C1.009990976! 8.15EC08! 4!
!KCTD7! C1.010382907! 3.12EC05! 4!
!TMC8! C1.010420379! 7.49EC05! 4!
!TRERF1! C1.011372912! 0.000122778! 10!
!IL16! C1.013127963! 7.19EC05! 4!
!ATF5! C1.013870994! 3.83EC05! 4!
!NMT2! C1.014215506! 0.001554975! 24!
!RTN4R! C1.017192114! 0.022422163! 24!
!FCGR1B! C1.01776657! 9.86EC05! 10!
!FAS! C1.017846845! 0.024787432! 10!
!NFKBIE! C1.017892315! 0.029224105! 24!
!TOR3A! C1.022607872! 0.003286262! 24!
!BTG2! C1.026655332! 0.016581842! 1!
!GBP1! C1.028267937! 0.027490786! 10!
!ZCCHC24! C1.030188956! 0.000104053! 10!
!RELB! C1.03157367! 3.19EC05! 4!
!RNF125! C1.032123363! 0.000301167! 4!
!ATP2B1! C1.03788801! 7.85EC06! 10!
!LOC344887! C1.044946425! 0.010789359! 4!
!ACVR2A! C1.047285611! 0.000103929! 10!
!ZFYVE16! C1.048569713! 1.76EC05! 10!
!
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NLN! C1.050774899! 0.017119733! 4!
!SAMD4A! C1.051568149! 0.034402011! 10!
!SGTB! C1.0517475! 1.93EC06! 10!
!ARHGAP25! C1.052237902! 2.56EC08! 10!
!JAKMIP2! C1.052761271! 0.027454672! 24!
!PDE4DIP! C1.054055285! 0.010477912! 10!
!TRAF3IP3! C1.062143523! 0.000653719! 10!
!DPCD! C1.068060663! 0.000175423! 10!
!TLE3! C1.070497058! 0.004627151! 10!
!CA2! C1.076757213! 0.009864512! 10!
!PAK1! C1.081943684! 0.000333389! 10!
!PEA15! C1.082703192! 1.15EC05! 24!
!HIVEP1! C1.086939011! 0.002246749! 2!
!PTGIR! C1.08992229! 0.042090685! 10!
!CD48! C1.094235707! 0.030002029! 24!
!SLC29A3! C1.094682184! 0.042617616! 4!
!MXD1! C1.116551626! 3.67EC05! 4!
!SLC7A11! C1.117384188! 0.014800316! 10!
!C16orf54! C1.118173159! 0.000322366! 24!
!P2RY6! C1.119387416! 0.020219996! 4!
!SLC46A3! C1.122498284! 5.05EC09! 10!
!TAGAP! C1.129273443! 0.001658482! 1!
!SPATA12! C1.129284362! 0.004178064! 10!
!PLAU! C1.130136268! 0.001348149! 24!
!HEG1! C1.131821171! 0.021987704! 4!
!PTGS1! C1.137497504! 2.89EC06! 24!
!RAB7B! C1.137743652! 0.038250294! 24!
!HPSE! C1.147787511! 0.001487404! 24!
!GNG2! C1.15435356! 0.002410116! 10!
!P2RX7! C1.172723665! 0.000770697! 24!
!CYTL1! C1.189717129! 0.004155805! 24!
!NQO1! C1.193597707! 2.10EC06! 10!
!NUMA1! C1.201777113! 0.002706623! 4!
!MRPS6! C1.219032494! 0.016432575! 4!
!TESC! C1.219914851! 6.63EC05! 10!
!EHD1! C1.22292058! 0.000621808! 4!
!LOC285628! C1.239516984! 0.029861865! 1!
!VASH1! C1.248801459! 0.000457018! 10!
!NOD2! C1.251705045! 0.000483132! 2!
!MFSD2A! C1.256450115! 0.006737917! 2!
!KLRG1! C1.260079361! 0.000341258! 10!
!GPR84! C1.262407904! 0.014653574! 24!
!ITGAL! C1.268328785! 0.01606464! 24!
!
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TNFSF15! C1.293479624! 0.046565506! 4!
!SLC2A6! C1.293754364! 0.004188819! 24!
!TJP2! C1.296670922! 0.000115947! 10!
!TNFSF10! C1.297876733! 0.04091709! 4!
!BIRC3! C1.319683571! 0.00779449! 24!
!TLR7! C1.342508265! 8.06EC06! 4!
!TMEM138! C1.348565008! 1.07EC05! 10!
!ZBTB46! C1.361634124! 0.000683609! 24!
!PIR! C1.368139348! 1.35EC08! 10!
!ME1! C1.371401015! 5.44EC07! 10!
!TNF! C1.374692547! 0.000640579! 24!
!CLEC4A! C1.377369856! 3.42EC06! 10!
!LXN! C1.399281292! 8.20EC07! 24!
!GPR68! C1.408268429! 0.004238373! 4!
!CXCL2! C1.44052364! 0.024392458! 24!
!SLC9A9! C1.460726595! 0.000612964! 10!
!BCL11A! C1.464786737! 0.009231081! 10!
!BCL3! C1.519292419! 1.37EC06! 4!
!NBPF1! C1.523916536! 0.001502375! 10!
!ASRGL1! C1.525060449! 2.28EC06! 10!
!TNFSF13B! C1.535665252! 1.92EC07! 24!
!SLC5A3! C1.535959823! 0.002751118! 4!
!CRHBP! C1.553849975! 0.000587068! 10!
!FBLIM1! C1.557861642! 0.007220932! 24!
!TMEM71! C1.569118286! 6.59EC06! 10!
!ARG2! C1.571531914! 0.002834606! 10!
!BCAR3! C1.607185286! 0.004912547! 24!
!TEF! C1.612090312! 2.36EC07! 24!
!CHST2! C1.63740843! 0.02910728! 10!
!MTHFD1L! C1.637651226! 1.30EC05! 24!
!SRGAP3! C1.644134234! 0.001061038! 10!
!CD200R1! C1.671368919! 0.001485256! 10!
!CD83! C1.682680879! 0.022906236! 2!
!RGS16! C1.692132553! 0.020132944! 10!
!KLHL13! C1.708937978! 0.009483796! 24!
!SLAMF7! C1.718616152! 0.023951314! 24!
!C1orf21! C1.72919737! 0.000937542! 10!
!CD274! C1.74042145! 0.004800619! 4!
!CD163L1! C1.777604388! 0.000181387! 24!
!KITLG! C1.815871583! 0.001017396! 4!
!HS3ST1! C1.843946079! 0.014803361! 2!
!PTGFRN! C1.861862967! 0.0004685! 10!
!PER3! C1.933565648! 2.78EC08! 24!
!
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SGPP2! C1.941393962! 0.014440102! 24!
!IRF1! C1.981440311! 2.94EC05! 2!
!HIVEP3! C1.996685266! 0.000571742! 24!
!LOC440934! C2.022652508! 0.045735038! 4!
!CIITA! C2.076825979! 1.08EC05! 24!
!GPRC5B! C2.109931988! 0.030962304! 10!
!C5orf20! C2.129351761! 0.011652281! 10!
!NR1D2! C2.14768144! 9.74EC13! 10!
!IFIT1! C2.192912361! 0.042143443! 10!
!CCL4! C2.299143199! 0.006910067! 10!
!TIFAB! C2.387018307! 0.007353268! 10!
!IL8! C2.442276848! 0.01981637! 4!
!PER2! C2.450384507! 4.37EC08! 24!
!MRC2! C2.589341666! 0.003636145! 24!
!CXCL1! C2.606922466! 0.03566627! 2!
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